Scope of this assessment

• We mapped your full site — 737 pages — and read 67 of them closely, chosen for signal.
• This report includes 24 drafted pages, each written for one buyer question.

Before you publish

Every specific in these pages (prices, names, dates, figures) traced to a verified source or was flagged inline. Still, you own what goes live — skim once, then publish. Nothing here was published for you.

AI visibility — where you stand today

More of your buyers now start with AI search — asking ChatGPT, Perplexity, Claude, or Google's AI Overviews — instead of working through a page of blue links. Whatever they ask, some source gets quoted back to them. This section is a read of what stands between you and being quotable, built from your own site and from public search results — not from putting those questions to the engines about you: whether your site presents you as one distinct entity an engine could resolve without guessing, whether your pages answer a buyer's question in the extractable form these engines lift, and who is publicly answering those questions today.

Today, buyer questions about URAC/NCQA accreditation strategy, 340B audit readiness, CARF behavioral health prep, and healthcare AI governance are each answered by dense fields of named specialist incumbents (Neolytix, Andros, Alinea Group, Virtue 340B, C4 Consulting, Compass Consultants, RediMinds) rather than by any single generalist authority — IHS's crawl shows it already competes across nearly all of these lanes but its case-study and comparison pages are the mechanism, not yet matched by third-party citation or press coverage found in this run. The core entity gap is that Thomas G. Goddard's unique former-URAC-COO/GC credential is asserted extensively on-site but is thinly corroborated in earned media outside self-published bios, LinkedIn, and directory listings (ZoomInfo, Crunchbase); no independent trade-press profile of Goddard or IHS surfaced in searches this run. Earned-media targets: Fierce Healthcare and HealthTech Magazines (already covering URAC AI accreditation news), Healthcare Innovation Group (covered URAC's first AI-accredited organizations), Modern Healthcare (Goddard's self-described 2025 honoree list warrants independent verification/follow-up), and CARF/URAC's own newsroom channels for co-marketing case studies.

The pages further down are the response to this read: each one takes a question you should own and answers it answer-first, with paste-ready structured data (JSON-LD) so a crawler can parse who you are and what you do. AI visibility is a mechanism — machine-legibility — not a promised outcome.

IHS is an accreditation and compliance consulting firm run by the people who used to run URAC — no junior associates, ever

Integral Healthcare Solutions (IHS) prepares healthcare organizations for accreditation, survey, and certification across nearly every major accrediting body in the country — URAC, NCQA, ACHC, CARF, NABP, DNV, HITRUST, NCCHC, and more. If you need to pass a survey, build a compliance program that will actually hold up under review, or design workforce and leadership capacity that survives contact with real operational pressure, IHS is built to do that work directly, not hand it to a bench of associates learning on your account.

IHS is not a fit for organizations that want the cheapest possible checklist review or a firm that specializes in one accreditor and refers you elsewhere for everything else. It is built for organizations that need someone who has sat on the other side of the table — reviewing, deciding, and defending accreditation decisions — and who can move fluently across bodies when your organization's programs span more than one.

Who is actually doing the work?

Every engagement at IHS is led by Thomas G. Goddard, the firm's founder, who was previously URAC's Chief Operating Officer and General Counsel. Goddard sat on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites, and served as project manager on URAC's successful effort to obtain deemed status as an accreditation organization from CMS — the kind of regulatory recognition that determines whether an accreditor's seal carries weight with government payers in the first place. IHS built its consulting model around that seat: someone who has made accreditation decisions, not just studied them, running your engagement from intake to survey day.

That principal-led model extends across the firm's bench of subject-matter leads. Susan DeMarino, RN, who previously served as Vice President and Director of Accreditation at URAC and directed case management at West Penn Hospital, leads case management and utilization review engagements. Maureen Plumstead, IHS's NCQA expert consultant, has worked as an NCQA reviewer since 1996. Nobody on an IHS engagement is a junior associate cutting their teeth on your accreditation cycle.

What makes IHS different from other accreditation consultants?

Most accreditation consulting firms specialize in a single accrediting body and refer clients elsewhere once a program falls outside their lane. IHS was built to do the opposite: cover URAC, NCQA, ACHC, CARF, NABP, DNV GL, HITRUST, NCCHC, and AAHRPP work under one roof, led by the same principal-level team regardless of which standard applies. URAC itself has certified IHS under its Health Care Management Certification Program — IHS states it is the only accreditation consulting firm to hold that certification, a distinction that speaks directly to the depth of URAC-specific expertise behind the firm's broader multi-accreditor practice.

That breadth matters because healthcare organizations rarely need just one accreditation. A health plan chasing NCQA Health Plan Accreditation may also need URAC pharmacy accreditation for a specialty pharmacy line, a CVO credentialing certification, and a compliance program that satisfies state Medicaid contract language at the same time. Fewer than 25 organizations nationwide hold dual URAC/NCQA CVO status — a fact that illustrates how narrow the pool of firms is that can genuinely operate across accreditors instead of just one.

What does IHS actually help organizations do?

IHS delivers four connected lines of work: accreditation readiness and consulting, compliance program development, credentialing and CVO consulting, and — through its Integral Workforce & Leadership Sciences practice — workforce and leadership capacity building. Accreditation readiness means gap analysis, mock surveys, policy and procedure development, and survey-day support across URAC, NCQA, ACHC, CARF, NABP, DNV GL ISO 9001, HITRUST, and NCCHC standards. Compliance program development means building the infrastructure — policies, audit tools, delegation oversight, quality committees — that keeps an organization in continuous compliance between surveys, not just ready for the one that's scheduled.

The credentialing and CVO practice helps organizations design or tighten credentials verification programs against URAC and NCQA standards, work that has become more consequential as payers and health systems increasingly require CVO accreditation from their delegated partners. And where compliance work stops at policy, IHS's workforce and leadership sciences practice picks up: building the human capacity — regulated, resilient, capable of holding complexity under pressure — that lets a compliance program actually function day to day, not just exist on paper.

Does IHS track new accreditation programs as they emerge?

Yes — accreditation is not a static target, and IHS tracks new programs as accrediting bodies stand them up, including the newest wave of healthcare AI governance accreditation. URAC's AI Accreditation program's first accredited organizations were Guidehealth, RediMinds, and SandsRx, and The Joint Commission has partnered with CHAI to launch its own Responsible Use of AI in Healthcare certification. As healthcare organizations deploy more AI into clinical and operational workflows, the accreditation landscape around AI governance is moving fast, and IHS is positioned to help organizations get ahead of it rather than scramble once a payer or regulator makes it a requirement.

How do I know this is worth the investment?

Accreditation failure and merger integration failure both carry real cost, and IHS's work is aimed squarely at avoiding both. Consider that seventy to ninety percent of healthcare M&A deals fail to deliver their projected value, and only 14% reach what research defines as successful integration — numbers that show how often organizations underinvest in the operational and compliance infrastructure that determines whether a deal, or an accreditation cycle, actually pays off. IHS's model — principal-led, multi-accreditor, built by people who used to make these decisions from inside the accreditor — exists to put your organization on the right side of that math.

What's the first step?

Book a free discovery call. Tell IHS which accreditation, compliance, or workforce challenge is in front of you, and you'll talk directly with the people who will actually do the work — not a sales rep who hands you off afterward.

Frequently asked questions

What accrediting bodies does IHS work with?

IHS consults across URAC, NCQA, ACHC, CARF, NABP, DNV GL, HITRUST, NCCHC, AAHRPP, and other major healthcare accrediting bodies, rather than specializing in a single one. That breadth lets a single engagement team support organizations that need to satisfy more than one accreditor at once.

Who actually runs my engagement?

Goddard, IHS's founder and former COO and General Counsel of URAC, leads engagements directly, supported by principal-level subject-matter leads like Susan for case management and utilization review and Maureen for NCQA work. IHS does not staff engagements with junior associates.

Is IHS only for health plans?

No. IHS works with health plans, pharmacies, credentialing organizations, behavioral health and human services providers, hospitals, correctional healthcare systems, and other organizations pursuing accreditation, compliance, or workforce development across the accrediting bodies relevant to their sector.

What if my organization needs more than one accreditation?

That is precisely the situation IHS is built for. Because the firm's principal-led team covers URAC, NCQA, ACHC, CARF, NABP, and other bodies simultaneously, organizations pursuing multiple accreditations — for example NCQA Health Plan Accreditation alongside URAC pharmacy or CVO accreditation — can work with one team instead of coordinating several single-accreditor vendors.

Does IHS help with AI governance accreditation?

Yes. IHS tracks emerging AI governance accreditation programs, including URAC's AI Accreditation program and The Joint Commission's Responsible Use of AI in Healthcare certification developed with CHAI, and advises organizations on positioning for these newer standards.

Who Runs IHS, and What Are Their Credentials?

Integral Health Solutions (IHS) is led by Thomas G. Goddard, who founded the firm in 2002 after serving as Chief Operating Officer and General Counsel of URAC. That distinction matters more than it might first appear: it means the person reviewing your policies and procedures before a survey is someone who once ran the operations of an accrediting body, not someone who has only ever sat across the table from one. IHS is built around that inversion of the usual consulting relationship, and it is why the firm describes its engagements as principal-led — a phrase that, on this page, we can actually explain rather than just assert.

What Is Goddard's Background at URAC?

Goddard spent his tenure at URAC on the inside of accreditation decisions, not adjacent to them. He served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites, which means he has personally read and scored the kind of documentation packages that IHS clients now submit. He also served as Project Manager on URAC's effort to obtain deemed status as an accreditation organization from the Centers for Medicare & Medicaid Services (CMS) — a regulatory recognition project that required understanding how CMS thinks about accreditation standards, not just how URAC wrote them. Few people advising healthcare organizations on accreditation strategy have sat on that side of the review table, at that level, for that long.

That combination — COO, General Counsel, review-team member, and CMS deemed-status project manager — is why IHS positions itself as principal-led. Clients get Goddard's judgment, not a rotating cast of junior associates learning the standards on the client's dime.

Is IHS Actually Recognized by an Accrediting Body, or Is That Just Marketing Language?

IHS states that it is the only accreditation consulting firm URAC has certified under its Health Care Management Certification Program, a certification that speaks directly to the firm's own compliance competency rather than simply its sales pitch. That's a meaningful distinction in an industry where most consulting firms describe themselves as "experts" without any accrediting body actually certifying that expertise. IHS invites prospective clients to verify this directly with URAC rather than take the claim at face value — which is precisely the kind of scrutiny the firm expects its clients to apply to their own vendors.

Who Else Is on the IHS Team?

IHS's bench includes named subject-matter experts recruited from the accrediting bodies themselves, not generalist compliance staff who learned NCQA or URAC or CARF standards secondhand. Susan DeMarino, RN, who previously served as Vice President and Director of Accreditation at URAC and directed case management at West Penn Hospital, brings direct URAC leadership experience to case management and utilization review engagements. Maureen Plumstead, the firm's current NCQA expert consultant, has worked as an NCQA reviewer since 1996 — meaning her read of an NCQA standard reflects nearly three decades inside NCQA's own review process, not a consultant's interpretation of a published manual.

This is the structural difference IHS points to when it says most single-body accreditation shops can't match its depth: the firm fields former insiders across multiple accrediting bodies — URAC, NCQA, and others — rather than one specialist covering one standard.

What Does "Principal-Led, No Junior Associates" Actually Mean for a Client?

It means the person who scopes your engagement is the same person doing the substantive review work on your policies, your evidence files, and your survey readiness — not a partner who sells the engagement and then hands it to staff who have never sat on an accreditation review team. IHS built its delivery model around former accrediting-body leadership specifically because accreditation standards are written by committees, interpreted by reviewers with institutional memory, and scored by people who know what a compliant program actually looks like in practice, not just on paper. That's not a credential a firm can outsource to junior staff and still deliver credibly.

Why Does It Matter That IHS's Founder Also Worked on CMS Deemed Status?

Deemed status is the mechanism by which CMS allows an accrediting body's survey to substitute for a direct CMS survey, and it is one of the more consequential regulatory relationships in U.S. healthcare accreditation. Having managed URAC's project to obtain that status, Goddard understands both sides of the deemed-status relationship: what CMS requires of an accrediting body, and what an accrediting body then requires of the organizations it accredits. That two-sided vantage point is part of what shapes IHS's approach to compliance strategy — the firm isn't just coaching clients toward a passing score, it's positioning them within a regulatory chain that runs from CMS through the accrediting body to the client organization.

Frequently Asked Questions

Is Goddard still actively involved in client engagements, or is IHS run by staff now?

IHS describes its delivery model as principal-led, meaning Goddard and the firm's named experts remain directly involved in client work rather than delegating engagements to junior associates. [confirm before publishing: current day-to-day engagement structure and whether Goddard personally reviews every client file].

What is Goddard's educational background?

Goddard holds a JD and a PhD. [confirm before publishing: institutions and years for JD/PhD, and full detail on any additional credentials to include in schema].

Does IHS work across multiple accrediting bodies, or specialize in one?

IHS works across virtually every major healthcare accrediting body — including URAC, NCQA, CARF, ACHC, DNV, NABP, HITRUST, and NCCHC — rather than specializing narrowly in one, which is the basis for the firm's claim to breadth that single-body accreditation shops typically can't match.

Who is Susan and what does she work on at IHS?

Susan is a former Vice President and Director of Accreditation at URAC who also directed case management at West Penn Hospital; at IHS she brings that URAC leadership background to case management and utilization review engagements.

How long has Maureen worked with NCQA?

Maureen has worked as an NCQA reviewer since 1996, and she serves as IHS's current NCQA expert consultant.

```

Page label: Service — Dual URAC/NCQA & Multi-Body Strategy Advisory

Buyer question: Should our organization pursue URAC, NCQA, or both, given our state footprint and payer contracts?

Which accreditation you need depends on your states, your payer mix, and which body your contracts actually require — often it's both

Most organizations answer this question backwards. They pick an accrediting body first, then discover eighteen months later that a health plan contract required the other one, or that a state Medicaid mandate they didn't map made the choice for them. IHS starts from the other end: your state footprint, your payer contracts, and your line-of-business mix determine which accreditation carries weight where you operate — and in a growing number of cases, the plain answer is both bodies, sequenced correctly, not one traded off against the other.

This is the one strategic question where IHS's founding vantage matters most. Thomas G. Goddard founded IHS in 2002 after serving as URAC's COO and General Counsel, where he sat on accreditation review teams for more than 200 HMOs, PPOs, and health websites and served as project manager on URAC's effort to win deemed status from CMS. IHS has since built out equally deep NCQA-side consulting, including work with Maureen Plumstead, an NCQA reviewer since 1996. No single-body shop can offer that dual vantage — most consulting firms are built around one accreditor because that's the world their consultants came from. IHS was built by someone who ran accreditation from inside URAC's leadership and then spent two decades helping organizations succeed under NCQA standards too.

Why does the accreditor choice even matter if the standards look similar on paper?

The accreditors aren't interchangeable, and the standards diverge in ways that show up in your contracts long before they show up in a survey. NCQA holds roughly 80% of the U.S. health plan accreditation market and is written into 26 state Medicaid mandates; its Health Plan Accreditation program alone touches over 1,200 health plan lines of business covering 169 million Americans. URAC, by contrast, tends to dominate categories NCQA doesn't reach as deeply — pharmacy, specialty networks, telehealth, and increasingly AI governance in healthcare. If your growth plan runs through state Medicaid contracts, NCQA is probably non-negotiable. If it runs through pharmacy benefit or specialty network contracts, URAC likely carries more weight. Many organizations need both because their book of business spans both worlds.

Can one organization realistically hold both URAC and NCQA accreditation at once?

Yes, but very few do it well, and the numbers make the difficulty visible. Fewer than 25 organizations nationwide currently hold dual URAC/NCQA CVO status, a scarcity that reflects how differently the two bodies structure their standards, their survey cycles, and their documentation expectations — not a lack of demand. Organizations that try to run both accreditations off a single generic compliance framework tend to over-build for one body and under-build for the other. The ones that succeed treat the two standard sets as related but distinct disciplines, mapped against a shared operational core rather than duplicated from scratch.

How does IHS decide which body — or which sequence — is right for us?

IHS builds the recommendation from your actual footprint, not from a generic accreditation roadmap. That means mapping every state you operate in against its specific accreditation and licensure requirements, auditing your existing and pipeline payer contracts for accreditation language, and identifying where a single accreditation satisfies multiple stakeholders versus where you genuinely need two. In many cases the right sequence is one body first — to stabilize a program and pass a first survey — followed by the second once the underlying infrastructure is proven, rather than pursuing both simultaneously and diluting attention across two survey cycles at once.

Does IHS actually deliver this work itself, or hand it to associates?

IHS delivers this advisory work principal-led, with no junior associates managing your strategy or your survey prep. Given how much of this decision rests on judgment calls about payer relationships, state regulatory posture, and which body's examiners will scrutinize what — this is not a place for delegation to staff without direct standards-body experience. Goddard and IHS's senior consultants, several of whom have worked accreditation from inside the bodies themselves, are the ones in the room with your leadership team.

What does a dual-body engagement typically include?

A dual-body engagement typically includes a state-by-state and payer-contract mapping exercise, a gap analysis run against both standard sets simultaneously, a build of shared policy and documentation infrastructure that satisfies both bodies without duplicating effort, and a sequenced survey-readiness plan for each accreditation. Where relevant, IHS also builds in room for adjacent programs — such as URAC's newer AI governance accreditation track — so the infrastructure you build now doesn't need to be rebuilt again in two years.

FAQ

Do we need both URAC and NCQA, or can we get by with one?

Whether you need one or both depends entirely on your payer contracts and state footprint, not on which accreditor is more prestigious. Some organizations legitimately only ever need one; others discover mid-engagement that a contract or state mandate requires the second. IHS's first deliverable in any multi-body engagement is a clear-eyed map of which contracts and states actually require what.

Is it more expensive to pursue both accreditations at once?

Pursuing both simultaneously without shared infrastructure is more expensive, because most organizations end up duplicating policy work, documentation, and survey prep across two parallel tracks. Building the two standard sets against a shared operational core — which is how IHS structures dual-body engagements — reduces that duplication substantially.

How long does it take to build out infrastructure for both bodies?

Timelines vary by how mature your current compliance infrastructure already is and whether you're pursuing the two accreditations concurrently or in sequence. [confirm before publishing: typical engagement timeline range for dual-body work]

What happens if our payer contracts require an accreditation we don't currently hold?

IHS maps contract-required accreditation language during the initial engagement so this gets identified before it becomes a contract compliance problem, not after. If a gap is found, the readiness plan is built around the contract deadline as a hard constraint.

Does Goddard's URAC background create any conflict when advising on NCQA strategy?

No — IHS's NCQA-side work is led by consultants with direct NCQA reviewer experience, including Maureen, who has served as an NCQA reviewer since 1996. Goddard's URAC background and IHS's NCQA depth are complementary, which is the entire premise of the dual-body advisory: neither side of the recommendation is guesswork.

Label: Post-Merger Human Integration for Healthcare M&A and PE — What specifically does "post-merger human integration" add beyond standard financial/operational integration work?

Standard post-merger integration protects the deal model. Human integration protects the people who have to live inside it after the model stops mattering.

Most post-merger integration work in healthcare M&A is built by finance and operations consultants: they reconcile chart of accounts, harmonize EHR systems, consolidate vendor contracts, and build the 100-day plan. That work is necessary. It is also not the reason 70 to 90 percent of healthcare M&A deals fail to deliver their projected value, with only about 14% of deals reaching what research calls successful integration. IHS's post-merger human integration work sits alongside the financial and operational workstream and addresses the layer those teams are not built to see: what happens inside clinical staff, middle managers, and leadership when their employer, their reporting lines, their clinical protocols, and often their professional identity change on the same closing date.

IHS's approach combines regulatory and contractual fluency with a distinct capability most integration consultancies do not carry in the same person: formal training in grief and loss processing, applied to organizational change rather than individual bereavement. The firm's principal brings both a JD-level read of the deal's compliance and contractual obligations and a Certified Compliance and Ethics Professional (CCEP) grounding, paired with somatic and nervous-system-informed change work. That combination — regulatory literacy plus grief-work literacy, in one advisor, on one engagement — is not something IHS has found replicated elsewhere in U.S. healthcare consulting. That absence is based on IHS's own review of the market, not an independently audited claim, and should be read as a self-described positioning rather than a verified industry fact.

What actually breaks in a healthcare merger that financial integration doesn't fix?

What breaks is trust, sequencing, and nervous-system regulation among the staff who have to keep delivering patient care while their organization is being rebuilt around them. Financial and operational integration teams answer "what changes" — new systems, new policies, new org charts. They rarely answer "how does a 20-year clinical staff absorb this without checking out, without quiet quitting, without the malpractice-adjacent errors that come from a workforce operating in chronic low-grade fight-or-flight." Compliance risk in the first 12 months post-close is disproportionately a human-behavior risk, not a systems risk: staff who don't understand or trust the new chain of command misreport, underreport, or simply stop reporting.

Why does a healthcare merger need someone with both legal and grief-work training?

Because the two disciplines answer different halves of the same question, and healthcare M&A needs both answered together. The legal and regulatory half determines what the organization is contractually and statutorily obligated to do — accreditation continuity, licensure transfer, credentialing files, payer contract assignability, HIPAA business associate agreements surviving the transaction. The human half determines whether the people executing those obligations are in a state to execute them well. A change-management consultant without regulatory depth can misjudge which anxieties are legally grounded and which are not. A compliance consultant without grief-work training will read staff resistance as a training problem or a communications problem, when it is frequently an unprocessed loss reaction — loss of autonomy, loss of a known chain of command, loss of professional identity tied to the acquired organization's name or mission.

What does an IHS post-merger human integration engagement actually include?

It includes a structured assessment of where regulatory obligation and human capacity intersect across the first 100 days to 12 months post-close. That typically covers: mapping which accreditation, licensure, and credentialing continuity requirements carry hard deadlines that intersect with staff turnover risk; identifying which departments or clinical teams are showing early signs of disengagement, attrition risk, or reporting breakdown; structuring leadership communication sequencing so that regulatory changes are announced in a way that accounts for how people actually absorb change under uncertainty; and coaching acquiring-side and acquired-side leadership on pacing decisions so the deal's compliance timeline and the workforce's absorptive capacity move together rather than working against each other.

Who is this for, and who should look elsewhere?

This work is built for healthcare organizations and private equity operating partners managing an acquisition, merger, or divestiture where clinical staff retention and accreditation continuity both matter to deal value. It is not a replacement for a financial integration firm, an HR/benefits harmonization vendor, or deal counsel — IHS's human integration work is designed to run alongside those functions, informed by the same regulatory literacy IHS brings to its core accreditation consulting practice, not instead of them.

How is this different from a standard change-management consultant?

A standard change-management consultant typically works from a communications and training framework: town halls, FAQ documents, manager talking points, pulse surveys. IHS's approach starts from the same regulatory ground its accreditation and compliance consulting work stands on, then layers in formal grief and loss processing methodology adapted for organizational contexts rather than individual therapy. The result is diagnostic before it is prescriptive: rather than assuming every integration needs the same communications cadence, the engagement first identifies which parts of the organization are dealing with a genuine loss reaction and which are dealing with a genuine regulatory-comprehension gap, because the interventions for those two problems are not the same.

Frequently Asked Questions

Is this a licensed therapy or clinical service?

No. This is organizational consulting informed by grief and loss frameworks and nervous-system-informed change principles, not individual clinical treatment. Staff needing individual clinical support are referred to appropriate licensed providers; this engagement works at the organizational and leadership level.

How early in a deal should this engagement start?

Ideally during due diligence or immediately at signing, before the 100-day plan is finalized, because workforce risk factors identified early can be built into the integration timeline rather than retrofitted after attrition or compliance incidents have already occurred.

Does this replace our existing HR or change-management vendor?

No. It runs alongside existing HR, benefits, and change-management functions and focuses specifically on the intersection of regulatory continuity and workforce capacity — the layer those vendors are not typically staffed to assess.

Who leads this work at IHS?

The engagement is led directly by IHS's principal team, not delegated to junior associates, consistent with how IHS staffs its accreditation and compliance consulting engagements.

What industries or deal types does this apply to?

Healthcare-sector mergers, acquisitions, and divestitures — health plans, hospitals, behavioral health and substance use treatment organizations, pharmacy and PBM entities, and other accredited or accreditation-seeking healthcare organizations — where clinical staff continuity and accreditation or licensure obligations are both in play.

Book a free discovery call to discuss whether a post-merger human integration engagement fits your transaction timeline.

```

For a multi-site or multi-service-line behavioral health organization, the right question isn't "who knows CARF" — it's who can hold your whole accreditation footprint at once

Boutique CARF-only shops know CARF well. That's their entire business, and for a single-program provider seeking one accreditation, that focus can work fine. The problem shows up when your organization looks the way most behavioral health organizations actually look today: a group home here, an opioid treatment program there, a crisis intervention line, maybe a day treatment program for youth, sitting alongside a payer contract that also requires NCQA or URAC credentialing infrastructure. A CARF-only firm can walk you through the CARF standards manual. It generally cannot also tell you how your case management documentation needs to satisfy a health plan's URAC Case Management standards, or how your credentialing files need to hold up under an NCQA CVO audit at the same time. IHS was built by a former URAC COO and General Counsel, and has since built out case studies and working practice across CARF service lines from group homes and adult day services to opioid treatment programs, crisis intervention, day treatment for youth, and core behavioral health accreditation. When your organization spans more than one CARF service category — or spans CARF plus a payer-facing accreditation — you're not choosing between "CARF experts" and "generalists." You're choosing between a firm that knows one standards manual and a firm that has sat inside the accreditation infrastructure of the industry itself.

Why does CARF market share matter if I only need one accreditation?

It matters because CARF's dominance in behavioral health is exactly why serious CARF experience is worth more than niche-only familiarity. CARF holds 33.9% of the U.S. mental health treatment facility accreditation market, ahead of The Joint Commission's 25.9%, according to SAMHSA's N-SUMHSS 2024 data. That scale means CARF surveyors see everything — well-run multi-site systems and single-location shops alike — and their standards interpretation reflects that breadth. A consulting firm that has only ever prepared organizations for one CARF service line sees a narrower slice of that surveyor behavior than a firm working across group homes, opioid treatment programs, adult day services, transition services, and crisis intervention simultaneously. Pattern recognition across service lines is what catches the standard your internal team didn't know applied to your specific configuration.

What does "principal-led" mean when I'm comparing IHS to a CARF-only boutique?

Principal-led means the person who understands your organization's accreditation strategy is the same person doing the work, not a junior associate trained on a single manual. IHS was founded by Thomas G. Goddard, who served as COO and General Counsel of URAC and sat on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites before founding IHS in 2002. That background isn't CARF-specific — it's regulatory and accreditation infrastructure, full stop, which is precisely the vantage point needed when your organization's compliance picture involves more than one accrediting body at once. A boutique CARF shop's principal may be excellent at CARF. They typically haven't sat inside the machinery of a different accrediting body's deemed-status negotiations with CMS, or built credentialing infrastructure that has to satisfy both URAC and NCQA. That's a different kind of depth, and it's the kind multi-site, multi-service-line organizations need.

What if my organization really is single-site and single-service-line?

If you run one program, in one location, seeking one CARF accreditation with no other regulatory or payer-facing accreditation on the horizon, a dedicated CARF-only consultant may be a reasonable, cost-effective fit. IHS is candid about this: our advantage is depth across the accreditation landscape, not a narrower price point for a narrower job. The organizations that get the most value from working with IHS are the ones where CARF is one piece of a larger compliance picture — multiple service lines, multiple locations, a parallel URAC or NCQA requirement, or an internal team that needs program-development work, not just survey preparation.

Does IHS use junior staff to do the survey prep work?

No — IHS's engagement model is built around direct principal involvement rather than handing client work to junior associates who then report up. This is a deliberate structural choice, not a marketing line: across CARF, URAC, NCQA, ACHC, and other accrediting bodies, the person setting your accreditation strategy stays involved through the engagement rather than delegating it to staff learning on your file.

How does IHS's CARF work connect to the rest of my compliance program?

It connects because most behavioral health organizations don't have a "CARF problem" in isolation — they have a compliance program that has to satisfy CARF standards, payer credentialing requirements, and often case management or utilization review expectations simultaneously. IHS's compliance program development and case management and UM practices sit alongside the CARF work specifically so a multi-site organization doesn't have to coordinate three separate vendors who don't talk to each other.

FAQ

Is IHS a CARF-only consulting firm?

No. IHS works across CARF, URAC, NCQA, ACHC, NABP, and other major healthcare accrediting bodies, which is the firm's core differentiator against single-body specialist shops.

How many CARF service lines has IHS worked with?

IHS maintains documented case work across a wide range of CARF service categories, including group homes, adult day services, opioid treatment programs, crisis intervention, day treatment for youth, transition services, employment planning, dementia care, and sobering centers, among others.

Why would a multi-site behavioral health organization choose a multi-body firm over a CARF specialist?

Because multi-site organizations rarely face a single accreditation question in isolation — they're usually managing CARF alongside payer credentialing, case management standards, or a parallel accrediting body, and a single-body specialist typically can't advise across that whole picture.

Does working with IHS cost more than a CARF-only boutique?

Engagement scope and cost depend on the size and complexity of your organization; a single-site, single-service-line provider may find a narrower CARF-only engagement sufficient. [confirm before publishing: pricing structure or ranges, if IHS wants to state them]

Who at IHS actually does the CARF preparation work?

IHS's engagement model keeps a principal directly involved in the client relationship and preparation work rather than delegating engagements to junior staff.

```

NEW /340b-contract-pharmacy-independent-audit-services

Buyer question addressed: Does our contract pharmacy arrangement require an annual independent 340B audit under current HRSA guidance?

Yes — if you use contract pharmacy arrangements under 340B, HRSA expects you to conduct an independent audit at least annually, and to be able to produce it on demand

HRSA's Program Integrity guidance places the burden of proof for contract pharmacy compliance squarely on the covered entity, not the contract pharmacy or the third-party administrator managing the split-billing software. An independent audit — one conducted by a party outside the entity's own compliance staff — is the standard HRSA auditors and manufacturers expect to see when they ask how a covered entity knows its contract pharmacy arrangements are diversion-free and duplicate-discount-free. If your last audit was performed in-house, or performed by the same TPA that runs your claims accumulator, you have a documentation gap, not a compliance program.

Integral Healthcare Solutions (IHS) built its 340B practice the way it built every other line of its consulting work: principal-led, with the person managing the audit answerable directly to you, not routed through a bench of junior associates learning the program on your engagement. That distinction matters more in 340B than almost anywhere else in accreditation and compliance consulting, because a mis-scoped audit doesn't just cost you a finding — it costs you the discount on every covered outpatient drug run through the arrangement in question, retroactively, until the entity can prove otherwise.

What counts as a "contract pharmacy arrangement" that triggers the audit expectation?

Any arrangement where a covered entity dispenses 340B drugs through a pharmacy it does not own or directly operate counts as a contract pharmacy arrangement, and HRSA's expectation applies whether you have one contract pharmacy or fifty. This includes retail contract pharmacies, specialty contract pharmacies, and increasingly mail-order and telehealth-adjacent dispensing models that route prescriptions through third-party pharmacy networks. Each arrangement needs its own documented compliance oversight — a single umbrella audit that references "contract pharmacies" collectively, without arrangement-level testing, is a common finding, not a defense.

How often does an independent audit actually need to happen?

HRSA guidance and manufacturer expectation both point to at least annually, with many covered entities running semi-annual internal reviews between full independent audits when their contract pharmacy volume or manufacturer restricted-access exposure is high. A single annual audit is the floor, not the target, for entities with multiple contract pharmacy relationships, split-billing software dependencies, or any history of prior findings. Entities that treat the audit as a once-a-year compliance errand — rather than a standing program with documented ongoing monitoring — are the ones that get caught flat when a manufacturer or HRSA site visit lands between audit cycles.

What does an independent 340B contract pharmacy audit actually test?

A proper audit tests three things: eligibility (was the patient a legitimate patient of the covered entity at the time of the prescription), duplicate discount prevention (was the claim carved in or out of Medicaid correctly, and is there proof), and diversion prevention (did the drug go to an eligible patient, not resold or diverted outside the covered entity's own patient population). Auditors sample claims across contract pharmacy locations, trace prescriptions back to qualifying patient encounters in the entity's own records, and test the accumulator or TPA's logic against actual claims data rather than trusting vendor-supplied summary reports. Where entities fail is almost always in eligibility documentation — the patient record exists, but the audit trail connecting the prescription to a qualifying encounter at the covered entity does not.

What's the difference between IHS and a 340B-only audit specialist?

A 340B-only audit shop knows contract pharmacy compliance deeply but usually stops at the program boundary — they audit the 340B arrangement and hand you a findings report. IHS runs the audit inside a broader compliance and accreditation practice led by Thomas G. Goddard, the firm's founder and a former COO and General Counsel of URAC, which means the same team that tests your contract pharmacy eligibility logic can also see how that finding intersects with your NCQA, URAC, or ACHC accreditation standards, your credentialing program, or an upcoming CMS survey. Most 340B audit specialists have never sat inside an accrediting body's review process; IHS's principal has run more than 200 of them. That breadth changes how a finding gets remediated — not as an isolated 340B fix, but as part of the entity's overall compliance posture.

What happens if we skip the independent audit and rely on our TPA's reporting instead?

Relying solely on your third-party administrator's standard reporting leaves you exposed, because TPA reports are built to flag what the software is configured to catch, not to independently verify that the configuration itself is correct. An independent audit tests the configuration, the underlying claims data, and the documentation trail — the things a TPA dashboard cannot self-audit. Covered entities that have gone through a manufacturer audit or HRSA site visit after relying only on TPA reporting consistently describe the same experience: the software looked clean, and the underlying records didn't support it.

Frequently Asked Questions

Do we need a separate audit for every contract pharmacy, or can one audit cover all of them?

Each contract pharmacy arrangement needs arrangement-level testing within the audit, even if it's delivered as a single consolidated report. Sampling claims from only one or two locations and extrapolating findings across your full contract pharmacy network is a common shortcut that does not hold up under HRSA or manufacturer scrutiny.

Who is qualified to perform an "independent" 340B audit?

HRSA does not certify or license 340B auditors, so "independent" means a party outside your own compliance staff's chain of accountability — someone without a stake in signing off on their own prior work. IHS performs these audits as part of its principal-led compliance practice, with the audit led directly by senior staff rather than delegated to associates unfamiliar with your program history.

What happens if the audit finds a duplicate discount or diversion issue?

You'll need a documented corrective action plan, and in duplicate discount cases, repayment to the affected payer or manufacturer. The audit's real value is catching this before a manufacturer or HRSA finds it independently — self-identified and self-corrected findings are treated very differently than those discovered externally.

How is this different from the 340B compliance work IHS already publishes on its audit guide?

The audit guide covers the compliance program broadly, this page focuses specifically on the independent audit requirement for contract pharmacy arrangements, since that's where most 340B risk concentrates for covered entities using retail or specialty contract pharmacy networks rather than in-house dispensing.

Can IHS help if we've already had a negative finding from a manufacturer or HRSA?

Yes — remediation after an existing finding is one of the most common reasons entities call IHS, and the same principal-led team that runs proactive audits also builds and documents corrective action plans for entities already under manufacturer or HRSA scrutiny.

If you're not certain your contract pharmacy arrangements would withstand an independent audit today, that uncertainty is the finding. Book a free discovery call with IHS to talk through your current audit cadence and where the gaps likely sit.

Page label: NEW /executive-coaching-for-healthcare-leaders-integrating-i-o-ps
Targets buyer question: What makes IHS's executive coaching different from generic physician burnout coaches?

IHS coaching is built on accreditation and organizational-psychology expertise, not a generic burnout curriculum retrofitted for healthcare

Most executive coaching sold into healthcare starts from the wellness side and works backward — a burnout framework, a resilience model, sometimes a physician-coach with a compelling personal recovery story, applied to whatever organization hires them. Integral Healthcare Solutions built its coaching practice from the opposite direction. It sits inside a firm that has spent two decades doing principal-led accreditation, compliance, and program-development consulting for health plans, CVOs, pharmacies, and behavioral health organizations across NCQA, URAC, CARF, ACHC, and NABP. The coaching is delivered by the same people who understand how a survey cycle, a corrective action plan, or a state Medicaid mandate actually lands on a leader's desk — not by a coaching brand that has bolted a healthcare vertical onto a generic executive-development product.

This work sits under IHS's Integral Workforce & Leadership Sciences practice, and it reads differently than the rest of the site on purpose. Where the accreditation pages talk in standards versions and survey windows, this practice talks about nervous-system regulation, meaning and purpose, and what it takes to lead from a regulated capacity rather than a depleted one. That shift in register is intentional. Compliance leadership and clinical leadership are not the same job, and the stress they produce is not the same stress. The coaching is designed for the second kind — for the people who carry the operational and regulatory weight of the organization, not just its clinical caseload.

What does IHS's coaching actually cover that a physician-coaching firm doesn't?

IHS coaching addresses the compliance and operational load that sits on top of clinical or executive responsibility — survey readiness, regulatory change, board and payer pressure, program-development timelines — because the coaches doing the work also do that work for a living. A physician-burnout coach, however skilled, is typically working from a clinical-wellness or psychology background applied to a healthcare setting they observe from the outside. IHS's coaches sit inside the accreditation and compliance engagements as consultants first. The coaching draws on organizational psychology and workforce sciences, but it is grounded in direct, current knowledge of what NCQA, URAC, CARF, and ACHC actually require, and what that requirement does to the humans responsible for meeting it.

That distinction matters most for leaders whose stress is structural rather than purely clinical — a CVO director facing a URAC deemed-status renewal, a health plan compliance officer managing an NCQA survey window, a behavioral health COO absorbing a CARF corrective action. Their exhaustion is not generic. It is produced by specific regulatory mechanics, and coaching that doesn't understand those mechanics can only address the symptom, not the source.

Who leads the coaching, and what is their background?

IHS's coaching is principal-led, consistent with every other service line the firm delivers — there are no junior associates rotated onto engagements. The firm was founded in 2002 by Thomas G. Goddard, a former COO and General Counsel of URAC who served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites and who was project manager on URAC's effort to win deemed status as an accreditation organization from the Centers for Medicare & Medicaid Services. That regulatory depth carries into the workforce and leadership practice: the coaches understand accreditation not as an abstraction but as lived operational reality, because they have sat inside it.

Is this coaching or is it therapy?

It is coaching, not clinical therapy, and it is built for leaders rather than patients. The work draws on somatic and nervous-system-informed frameworks because sustained regulatory and operational pressure produces a physiological load, not just a psychological one, and leaders who only address the cognitive layer tend to relapse into the same depleted patterns during the next survey cycle or the next compliance deadline. The goal is regulated capacity — the ability to hold complexity and pressure without leaking it into decision quality, team culture, or health.

Why would a health plan or accredited organization pay for this instead of a standard leadership-development vendor?

A standard leadership-development vendor sells a curriculum; IHS sells judgment built inside the exact regulatory environment the leader operates in. Because IHS's coaches are also its accreditation and compliance consultants, coaching conversations can move fluidly between "how do I lead my team through this" and "what does the surveyor actually expect here" — a combination that a pure leadership-development firm, however credentialed in psychology, cannot offer without a healthcare-regulatory bench behind it. For organizations already engaging IHS on accreditation or program development, the coaching extends naturally from work already underway rather than introducing a new vendor relationship and a new learning curve.

What does the coaching engagement look like?

Engagements are structured around the leader's actual operating context rather than a fixed module sequence, and length and cadence are matched to what's driving the need — a survey cycle, a leadership transition, a merger integration, or sustained role strain. [confirm before publishing: standard engagement length, session cadence, and pricing structure]. Coaching can run alongside an active IHS accreditation or compliance engagement, or stand alone for leaders whose organizations are not otherwise working with the firm.

Frequently asked questions

Is this only for physicians?

No. The coaching is built for healthcare executives, compliance officers, and operational leaders as much as clinicians — anyone whose role carries sustained regulatory or organizational pressure.

Does IHS have to be doing our accreditation work for us to use the coaching?

No. The coaching is offered as a standalone service, though it draws directly on IHS's accreditation and compliance experience regardless of whether the firm is engaged on a parallel project.

How is this different from an EAP or wellness benefit?

An employee-assistance program is typically reactive and generalized; this is proactive, leader-specific coaching grounded in the regulatory realities of the leader's own organization and role.

Who actually delivers the sessions?

Sessions are led by IHS principals with direct accreditation and compliance consulting experience, not by junior coaches or outsourced contractors.

Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

```

Label: Service — NEW /board-level-human-capital-risk-advisory-retainer

Buyer question: What does a quarterly board retainer on human-capital risk actually deliver versus a one-time culture assessment?

A quarterly retainer delivers standing board-level visibility into human-capital risk; a one-time culture assessment delivers a snapshot that is stale before the next accreditation survey or M&A close

The retainer puts a named principal in front of your board or governance committee on a fixed quarterly cadence, reporting on workforce risk the same way you'd expect risk or compliance to be reported — with trend lines, not a single point-in-time score. A culture survey tells you what people felt on the day they answered it. It does not tell your board whether turnover in a credentialed clinical unit is about to trip a staffing ratio your accreditor will flag, whether leadership churn during a merger integration is eroding the "regulated capacity" your frontline teams need to hold complex patient loads, or whether a compliance finding six months from now traces back to a workforce gap that was visible in this quarter's data and ignored. IHS built this retainer as Track D1 in its Integral Workforce & Leadership Sciences catalog specifically because the accreditation and compliance work we already do for governance-focused health plans, CVOs, and provider organizations kept surfacing the same problem: boards get clean quality and compliance dashboards, and almost nothing comparable on the human side of the operation that produces those numbers.

What's actually in the quarterly deliverable?

Each quarter you receive a board-ready human-capital risk report plus a live session where the principal walks your board or a designated committee through it. The report tracks leading indicators — turnover concentrated in credentialed or licensed roles, leadership bench depth against succession need, absenteeism and burnout signal in units under accreditation survey pressure, and nervous-system-level engagement data pulled from structured pulse checks rather than an annual survey nobody remembers filling out. Where the data intersects with active accreditation, credentialing, or compliance work IHS is already doing for the client, the report names the intersection directly — for example, if a CVO's credentialing throughput risk correlates with reviewer turnover, the board sees that connection made explicit rather than buried in two separate reports nobody cross-reads.

How is this different from a one-time culture or engagement assessment?

A one-time assessment answers "how is the organization doing right now"; the retainer answers "is human-capital risk trending toward a problem the board will own." A single assessment is useful for a point decision — a merger due-diligence window, a new CEO's first ninety days — but it can't tell your board whether the risk it flagged in March is better or worse in September, and it stops producing any signal the moment the invoice is paid. Given that seventy to ninety percent of healthcare M&A deals fail to deliver their projected value and only a small fraction reach what research calls successful integration, a board that treats human-capital risk as a one-time diligence checkbox is choosing not to see the leading indicators of that failure until it shows up in the numbers everyone already tracks — revenue, attrition, malpractice exposure. The retainer is built to catch it earlier, on a cadence a board can actually govern against.

Who presents to the board, and is it the same person every quarter?

The same principal presents every quarter — there is no rotating associate, no analyst reading a slide deck someone else built. IHS runs on principal-led delivery across its accreditation, compliance, and workforce-sciences work, and the board retainer is no exception: continuity of the person in the room is part of what makes a quarterly cadence useful, because pattern recognition across quarters lives with a person, not a template.

Does this replace our existing culture or engagement survey vendor?

It doesn't have to replace an existing survey tool; it sits above it and translates what that tool produces into board-level risk language. Most engagement platforms are built to report to HR and operating leadership. The retainer's job is different: it takes whatever data exists — survey data, turnover data, accreditation and credentialing throughput data where IHS already has visibility into it — and turns it into the kind of quarterly risk narrative a board or audit-and-compliance committee is used to receiving from finance, legal, and quality. If no engagement tool exists yet, IHS can stand up lightweight structured pulse mechanisms as part of the retainer rather than requiring a separate procurement.

Who is this retainer built for?

This is built for boards and governance committees at health plans, health systems, CVOs, and multi-site provider organizations that already treat compliance and quality risk as standing board agenda items and want human-capital risk held to the same standard. It is not a fit for an organization looking for a single engagement survey to satisfy an accreditation requirement or a one-time culture read ahead of a leadership transition — those are better served by a discrete assessment engagement, not a recurring retainer.

FAQ

How long is the retainer term?

Retainers run on an annual agreement with quarterly delivery; terms and scope are set during a discovery call based on board size, number of entities under governance, and existing data sources. [confirm before publishing: standard minimum term length]

Can the retainer scope include subsidiary or affiliate boards, not just the parent board?

Yes — multi-entity governance structures are common among IHS's health plan and health system clients, and the retainer can be scoped to report at the parent level, the subsidiary level, or both, with reporting cadence adjusted accordingly.

Does the retainer produce anything usable for an accreditation survey or CMS review?

The quarterly reports are built as internal board governance documents first, but because they track workforce risk indicators that many accreditors and CMS reviewers also probe — staffing stability, credentialed-role turnover, leadership continuity — clients frequently find the underlying data set useful when preparing accreditation or regulatory documentation. It is not designed as a submission document itself.

What size organization is this priced for?

Pricing depends on entity count, board structure, and data complexity and is set during a discovery call rather than published as a flat rate. [confirm before publishing: pricing tiers or starting range, if any]

Who at IHS actually runs this — is it the same team doing our accreditation work?

The retainer is delivered by IHS's workforce-sciences principal, coordinated with whichever principal already leads your accreditation or compliance engagement, so risk signals surfaced in one line of work reach the board through the other rather than sitting in two disconnected files.

Book a free discovery call to scope a board retainer against your governance structure.

Label: Comparison — What does URAC's Health Care AI Accreditation actually require of us as a developer vs. a user?

URAC's Artificial Intelligence in Healthcare 1.0 program splits requirements by role: developers must prove how their model was built, validated, and monitored; users must prove how they selected, implemented, and oversee that model inside clinical or operational workflows

URAC did not write one AI standard and hand it to everyone. It wrote a Developer track and a User track inside the same Artificial Intelligence in Healthcare 1.0 program, because the accountability is different at each stage of the AI lifecycle. A company that builds a clinical decision-support algorithm has to answer for training data, bias testing, and model validation. A health plan or health system that buys that algorithm and deploys it in a care pathway has to answer for vendor oversight, human review points, and outcome monitoring. Organizations that do both — build and deploy — pursue both tracks, which is what a Developer + User designation signals.

This is a young accreditation category, and precision about what each track actually requires matters more than it does in mature programs, because there is not yet a large body of accredited organizations to benchmark against. IHS was built by people who sat inside URAC's standards and review process before this program existed — Thomas G. Goddard, IHS's founder, was URAC's COO and General Counsel and served as Project Manager on URAC's effort to obtain deemed status as an accreditation organization from CMS. That is the vantage point IHS brings to a program still finding its shape.

What does the Developer track require?

The Developer track requires an organization to document and defend how its AI model was built, tested, and is maintained over time — not just what the model outputs. Reviewers expect evidence of data governance (where training data came from and how it was vetted for representativeness and quality), bias and fairness testing across relevant populations, model validation methodology, and a defined process for monitoring model drift and performance degradation after deployment. Developers also need documented escalation paths for when a model underperforms or produces an unsafe recommendation, and a change-management process for retraining or updating the model without silently altering its clinical behavior.

What does the User track require?

The User track requires an organization to prove it selected, implemented, and oversees a third-party AI tool responsibly inside its own operations — the accountability sits with the deploying organization, not the model builder. That means a documented vendor due-diligence process before adoption, clear human-in-the-loop checkpoints where clinical or operational staff review AI output before it drives a decision, staff training on the tool's intended use and known limitations, and ongoing monitoring of real-world outcomes once the tool is live. A user organization has to be able to show it isn't simply trusting a vendor's marketing claims — it has its own oversight structure running in parallel.

Who needs the combined Developer + User designation?

An organization needs the combined designation when it both builds an AI tool and deploys that same tool in its own clinical or operational workflow, rather than selling it to someone else to deploy. This is common among health systems, health plans, and virtual-care organizations that build proprietary triage, care-management, or utilization-review models in-house and then run them directly. TimelyCare is one example of an organization that pursued the full Developer + User path rather than splitting the two roles across separate accreditations, earning full accreditation under the program in 2026. Organizations that license a vendor's model but never touch its underlying design typically only need the User track; pure AI vendors selling into healthcare without deploying the tool themselves typically only need the Developer track.

How is this different from The Joint Commission's AI certification, or from doing nothing?

URAC's program and The Joint Commission's Responsible Use of AI in Healthcare certification, developed with CHAI and announced in mid-2026, are both responding to the same regulatory pressure but are not identical programs, and "doing nothing" is no longer a defensible position for an organization deploying AI in clinical decisions. The two accrediting bodies emerged from different traditions — URAC from managed-care and health-plan standards, The Joint Commission from hospital and facility standards — and organizations operating across both settings should expect to be asked which framework, or both, applies to their AI use. What doesn't change across either framework is the underlying expectation: documented governance, tested and monitored models, and human oversight that can be demonstrated to a regulator, a payer, or a plaintiff's attorney, not asserted informally.

Why work with a firm that has been inside URAC's own machinery rather than a generalist AI-compliance vendor?

A firm that has sat on the accreditor's side of the table reads a new standard differently than a firm reverse-engineering it from the public standards document alone. IHS's principal built part of the accreditation infrastructure this program descends from — reviewing more than 200 HMOs, PPOs, and health websites on URAC accreditation teams and running the CMS deemed-status project that established URAC as a federally recognized accrediting body. That is a different starting point than a generalist consultant reading URAC's AI standards for the first time alongside you. IHS engagements are principal-led — no junior associates learning the standard on your engagement — which matters most in a program this new, where there is little precedent to fall back on and a great deal of judgment involved in interpreting intent behind the written standard.

FAQ

Do we need both tracks if we build our own AI tool but also let outside partners use it?

Yes, in most cases — if you build the model, you need the Developer track regardless of who else uses it, and if you also deploy it inside your own operations, you need the User track as well. Partners who use your tool independently would need their own User-track accreditation for their deployment of it.

Can a health plan pursue User-track accreditation for a vendor's AI tool without the vendor being accredited?

A health plan can pursue User-track accreditation for its own oversight of a vendor's tool, but reviewers will still expect visibility into how that vendor built and validated the model, which is easier to document if the vendor itself holds Developer-track accreditation. Working with a vendor that lacks any documentation trail on model development makes the user organization's own accreditation preparation considerably harder.

How long does AI accreditation preparation typically take?

Timelines depend on how mature your existing AI governance documentation already is, so ask for a scoped estimate against your current state rather than a generic industry figure. [confirm before publishing: typical engagement duration]

Does URAC's AI accreditation replace the need for HIPAA or HITRUST-type security certification?

No — URAC's Artificial Intelligence in Healthcare program addresses model governance, validation, and oversight, not data security controls, so organizations typically need both an AI accreditation and a separate security framework such as HITRUST where sensitive health data is involved.

Were Guidehealth, RediMinds, and SandsRx accredited under the Developer track, User track, or both?

Guidehealth, RediMinds, and SandsRx were the first organizations to earn URAC's AI Accreditation; which specific track each pursued is organization-specific and should be confirmed against URAC's current accreditation directory rather than assumed. [verify: track designation per organization]

How do we prepare governance documentation for AI risk management, transparency, and oversight before applying?

You prepare AI governance documentation by building four things before you file anything: an AI inventory that names every model touching clinical or member-facing decisions, a risk classification tied to what each model actually does, a documented human-oversight point for every high-risk use, and a change-management log that tracks retraining and drift over time. Accreditors reviewing AI programs — URAC's AI Accreditation program among them — are not grading your technology. They are grading whether your organization can prove, on paper, that it controls the technology. That distinction drives almost every documentation failure IHS sees when organizations self-prepare.

Integral Healthcare Solutions was founded in 2002 by Thomas G. Goddard, a former COO and General Counsel of URAC. That background matters here specifically: Goddard sat on URAC review teams for accreditation bodies before AI programs existed, and the documentation logic AI accreditors now require — inventory, classification, oversight, audit trail — descends directly from the same review discipline URAC has applied to health plans, pharmacies, and case management programs for two decades. IHS builds AI governance documentation the way it builds every other accreditation submission: principal-led, standard-by-standard, with no junior associates drafting language the reviewer will eventually question.

What has to be documented before an AI accreditation or certification application goes in?

Before you apply, you need a written AI governance framework covering four domains: model inventory and purpose, risk tiering, human oversight and override authority, and monitoring for performance drift or bias over time. Reviewers want to see who owns the model, who can shut it off, what happens when it's wrong, and how you'd know. This applies whether you're pursuing URAC's Artificial Intelligence in Healthcare Accreditation, preparing for The Joint Commission and CHAI's Responsible Use of AI in Healthcare (RUAIH) certification, or building internal governance ahead of either.

The inventory has to be specific — not "we use AI for triage support" but which model, which vendor or internal build, which decision it influences, and which population it touches. Risk tiering separates administrative-only tools (scheduling, transcription) from clinical or coverage-determination tools, because oversight expectations differ sharply between the two. This is where organizations that write documentation after the fact tend to get flagged: reviewers can tell when a governance policy was drafted to match the standard rather than to describe what the organization is actually doing.

Who has to sign off on AI oversight documentation internally?

Oversight documentation needs a named accountable owner — not a committee, a person — who can explain the model's function, its failure modes, and the override path, in the same room as a reviewer. Most standards expect a governance committee with clinical, compliance, and technical representation, but committees don't answer questions in an interview; the accountable owner does. Boards and C-suites increasingly want to see this named-owner structure before they'll approve an AI accreditation application at all, since it's their exposure if the documentation doesn't hold up in a survey.

How is AI governance documentation different from standard compliance documentation?

AI governance documentation has to prove ongoing monitoring, not just a point-in-time policy, because AI models change behavior as they retrain or as the population they serve shifts. A standard compliance policy — say, a grievance procedure — can sit static for a survey cycle. An AI oversight policy has to show a monitoring cadence, a drift-detection method, and a record of what happened the last time the model underperformed. Reviewers are increasingly asking for that record, not just the policy that promises to keep one.

What are early adopters of AI accreditation actually submitting?

Early adopters are submitting governance frameworks built around named accountable owners, documented risk tiers, and monitoring logs rather than aspirational policy language. URAC's AI Accreditation program's first accredited organizations — Guidehealth, RediMinds, and SandsRx — went through this exact documentation build before their applications were reviewed. TimelyCare later earned full accreditation under URAC's Artificial Intelligence in Healthcare 1.0 Developer + User Program, a signal that both AI developers and AI users are now expected to carry this documentation, not just the organizations building the models.

Should we wait for URAC or Joint Commission/CHAI standards to settle before documenting?

No — waiting costs you more than building now, because the underlying documentation (inventory, risk tiers, oversight, monitoring) is the same regardless of which program you eventually pursue. URAC's AI Accreditation program and The Joint Commission's RUAIH certification, developed with CHAI and announced in mid-2026, both grade the same governance fundamentals even where their specific standards diverge. Organizations that build the documentation infrastructure first can decide which accreditor to apply to later; organizations that wait for a settled standard often find they're starting the inventory and oversight work from zero once they finally decide.

How does IHS help build this documentation?

IHS works directly with your compliance, clinical, and technical leads to draft the governance framework, gap-test it against the specific standard you're targeting, and prepare your team for the interview questions a reviewer will actually ask. This is principal-led work — the same standard-by-standard, no-junior-associate model IHS applies across URAC, NCQA, CARF, ACHC, and every other accrediting body it works with — applied to a newer, faster-moving standard. Because IHS's principal has reviewed accreditation submissions from the inside, the documentation build starts from what a reviewer needs to see, not from a generic template.

FAQ

Do we need an AI accreditation if we're only using AI for administrative tasks?

Administrative-only AI use — scheduling, transcription, back-office automation — carries lower risk-tier expectations, but most governance frameworks still require it to appear in the inventory and be classified, even if it doesn't trigger the oversight and monitoring requirements that clinical or coverage-determination AI does.

How long does it take to build AI governance documentation from scratch?

Timelines depend on how many models are in use and how mature your existing compliance infrastructure is; organizations with an established accreditation program (URAC, NCQA, or similar) can often extend existing governance structures, while organizations building from zero need more runway. [confirm before publishing: specific timeline ranges IHS quotes clients]

Can the same documentation support both URAC AI Accreditation and Joint Commission/CHAI RUAIH certification?

Much of the underlying documentation — model inventory, risk classification, oversight structure, monitoring logs — supports both, since the two programs grade similar governance fundamentals even though their specific standards and scoring differ.

Who at our organization needs to be involved in preparing this documentation?

Typically a named accountable owner for AI governance, compliance leadership, clinical leadership if models touch clinical decisions, and technical staff who can describe how each model actually functions and fails.

Does IHS write the documentation for us or guide our team through writing it?

IHS works principal-led alongside your team — drafting framework language, gap-testing it against the standard, and preparing staff for reviewer interviews — rather than handing documentation off to junior associates unfamiliar with your organization.

NEW /how-does-urac-s-ai-accreditation-differ-from-the-joint-commi

Label: Process — buyer question: "How does URAC's AI accreditation differ from The Joint Commission/CHAI's RUAIH certification?"

URAC's Artificial Intelligence in Healthcare accreditation and The Joint Commission/CHAI's RUAIH certification differ in structure, scope, and what they actually attest to — not just in name

URAC's Artificial Intelligence in Healthcare program accredits the organization operating or deploying an AI tool against a defined set of standards covering governance, data quality, monitoring, and accountability for outcomes. The Joint Commission's Responsible Use of AI in Healthcare certification, developed jointly with CHAI (the Coalition for Health AI) and announced June 1, 2026, is a newer entrant built around CHAI's assurance framework and positioned closer to a trust label for individual AI tools and use cases inside accredited health systems. Both responded to the same market pressure — health systems, payers, and vendors need some third-party signal that an AI tool is governed responsibly — but they built different instruments to supply it. Organizations evaluating either one need to understand what each body actually reviews, not just what it's called.

What does URAC's AI accreditation actually cover?

URAC's Artificial Intelligence in Healthcare accreditation reviews an organization's governance structure for AI tools: how the organization validates data inputs, monitors model performance over time, documents human oversight, and manages accountability when an AI-driven decision affects a patient or a claim. It is an organizational accreditation, meaning it certifies the entity's AI governance program as a whole rather than certifying a single algorithm or product in isolation. The program's first accredited organizations were Guidehealth, RediMinds, and SandsRx, spanning care management, AI product development, and pharmacy — a signal that URAC built the standard to travel across very different use cases rather than to fit one vertical. URAC later extended the program into a Developer + User track; TimelyCare earned full accreditation under that track in July 2026, covering both the developer side and the operational deployment of the AI tool.

What does The Joint Commission/CHAI's RUAIH certification cover?

The Responsible Use of AI in Healthcare certification, launched by The Joint Commission with CHAI, centers on CHAI's assurance framework for evaluating AI tools against criteria like validity, fairness, and transparency of use. It reads closer to a use-case certification layered onto The Joint Commission's existing accreditation relationship with a hospital or health system, rather than a freestanding accreditation of an organization's full AI governance apparatus. Because it launched more recently, the operational track record and scope boundaries are still developing, and organizations considering it should confirm current requirements directly with The Joint Commission and CHAI before treating any secondhand summary — including this one — as final.

Which one should a health system, payer, or AI vendor pursue?

The right program depends on what the organization is trying to prove and to whom. A health system already accredited by The Joint Commission that wants to fold AI governance into an existing survey relationship may find RUAIH the more natural fit. A payer, pharmacy, care-management vendor, or standalone AI developer that needs a portable, organization-level attestation of AI governance — one that doesn't depend on an existing Joint Commission relationship — is closer to URAC's use case, and URAC's own accredited cohort (spanning care management, product development, and pharmacy) suggests the standard was built for that breadth. Some organizations may eventually pursue both, the way many health plans hold both NCQA and URAC accreditations for different lines of business. The decision should be driven by the regulatory and contractual audiences the organization actually answers to — CMS, state Medicaid, health plan credentialing committees, or enterprise customers doing AI vendor due diligence — not by which name is more familiar.

Why does IHS track both programs instead of specializing in one?

Because IHS advises across virtually every major healthcare accrediting body rather than one, it can compare AI accreditation and certification options against the same organization's existing accreditation footprint instead of recommending in a vacuum. IHS was founded in 2002 by Thomas G. Goddard, a former COO and General Counsel of URAC, and the firm's work today spans URAC, NCQA, CARF, ACHC, NABP, DNV, HITRUST, and other bodies, delivered principal-led with no junior associates. That vantage point matters specifically here: a firm that only sells URAC engagements has an obvious incentive to recommend URAC's AI program regardless of fit, and a firm that only knows Joint Commission surveys will default to RUAIH. IHS's engagements are structured to evaluate which program — or combination — actually matches the organization's regulatory exposure and existing accreditation relationships.

Frequently asked questions

Is URAC's AI accreditation required for health plans or pharmacies?

No accrediting body currently mandates AI-specific accreditation the way many states mandate NCQA accreditation for Medicaid managed care contracts. URAC's Artificial Intelligence in Healthcare program is voluntary at this stage, though that could shift as regulators and enterprise customers begin asking AI vendors and health systems for third-party governance attestations.

Can an organization hold both URAC's AI accreditation and RUAIH certification?

There is no stated conflict between holding both, and an organization with a Joint Commission accreditation relationship plus a standalone AI product line could plausibly pursue each for a different audience. Confirm current compatibility and any overlap in documentation requirements directly with each body before committing resources to both simultaneously.

Does IHS help with RUAIH readiness or only URAC's program?

IHS advises across accrediting bodies rather than promoting a single one, so an engagement can compare readiness for URAC's AI accreditation against RUAIH or other emerging AI governance frameworks based on the organization's actual regulatory footprint. [confirm before publishing: current scope of IHS's RUAIH-specific service offering]

What's the fastest way to find out which AI accreditation fits our organization?

Book a free discovery call. IHS's principal-led review looks at your existing accreditation portfolio, your regulatory obligations, and your AI use case before recommending a path — rather than defaulting to whichever program the firm happens to sell.

Label: Comparison — Should our organization pursue URAC, NCQA, or both, given our state footprint and payer contracts?

URAC vs. NCQA: which one your organization actually needs, and when you need both

The right choice depends on your payer contracts and the states you operate in more than on any general reputation difference between the two bodies. NCQA dominates the health plan market — it holds roughly 80% of accredited US health plans and is written into 26 state Medicaid mandates, according to IHS's own market comparison. URAC, by contrast, covers a wider range of program types — pharmacy, case management, health networks, telehealth, AI governance — where NCQA either doesn't compete or isn't the prevailing standard. Organizations that assume "the bigger name" is the safer pick often end up accredited against the wrong standard for the contracts they're actually trying to win.

When does NCQA make more sense than URAC?

NCQA is the stronger choice when your organization is a health plan, MCO, or provider network operating in a state where NCQA accreditation is a Medicaid contracting requirement, or when your payer contracts explicitly reference NCQA standards. NCQA Health Plan Accreditation alone covers more than 1,200 health plan lines of business and roughly 169 million Americans — a scale that makes it the default expectation in commercial and Medicaid managed care. If your growth plan runs through state Medicaid RFPs, NCQA is very often not optional; it's a prerequisite line item in the bid.

When does URAC make more sense than NCQA?

URAC makes more sense when your organization operates in pharmacy, case management/utilization management, health networks, credentialing (CVO), telehealth, or the newer AI-in-healthcare space, where URAC either holds the dominant standard or is the only recognized accrediting body. URAC also holds CMS deemed status as an accreditation organization — a status IHS's founder, Thomas G. Goddard, was directly involved in securing while at URAC, having served as project manager on that effort. For pharmacy benefit managers, mail-service and specialty pharmacies, and case management/UM programs, URAC is frequently the standard payers and states actually ask for, not NCQA.

When do we need both URAC and NCQA?

Both accreditations are typically necessary when your organization runs distinct lines of business that each answer to a different dominant standard — most commonly a health plan arm (NCQA) paired with a credentialing verification organization, pharmacy, or case management function (URAC). Dual accreditation is genuinely rare: fewer than 25 organizations nationwide currently hold dual URAC/NCQA CVO status. That scarcity is itself informative — it means most organizations that need both are underestimating the operational lift of maintaining two full standards programs simultaneously, with two survey cycles, two sets of policy language, and two audit calendars.

How do we decide without guessing?

The decision comes down to mapping your actual payer contracts, state licensure requirements, and lines of business against what each accrediting body requires — not from a general sense of which brand is more respected. A firm that only sells one accreditation has a structural incentive to tell you that one is the answer. IHS was built around the opposite model: principal-led consulting across virtually every major healthcare accrediting body, so the standards recommendation isn't shaped by which accreditation the firm happens to sell. Goddard, IHS's founder, spent his pre-consulting career inside URAC as its COO and General Counsel, sitting on accreditation review teams for more than 200 HMOs, PPOs, and health websites — which is a different vantage point than a consultant who has only ever worked one side of one standard.

FAQ

Is URAC or NCQA more widely recognized by payers?

It depends entirely on the line of business — NCQA is more widely recognized for health plans and provider networks, while URAC is more widely recognized for pharmacy, case management/UM, credentialing, and specialty programs like telehealth and AI governance.

Does our state require a specific accreditation for Medicaid contracting?

Some states mandate NCQA accreditation specifically for Medicaid managed care contracting — NCQA cites 26 such state mandates — so this should be confirmed against your specific state's current Medicaid managed care requirements before choosing a standard. [confirm before publishing: verify current mandate status for the client's specific state]

Can one consulting firm manage both a URAC and an NCQA accreditation at once?

Yes, though it requires genuine depth across both standards rather than a single-body specialist stretching into unfamiliar territory — this is one reason IHS structures its engagements around principal-level consultants with hands-on experience across both bodies rather than junior associates learning on the client's timeline.

What happens if we pick the wrong accreditation for our contracts?

Choosing the wrong accreditation typically means re-doing the readiness work against a second standard later, after a payer contract or state RFP reveals the mismatch — a costly rework that a payer-contract and state-footprint review at the outset is designed to prevent.

How do we get a straight answer for our specific situation?

The most direct path is a discovery conversation where IHS reviews your state footprint, payer contracts, and lines of business against both standards before recommending a direction. You can book a free discovery call to start that review.

NEW /what-does-dual-accreditation-cost-and-how-long-does-cross-standard-gap-mapping-take

Cost page — targets the buyer question: "What does dual accreditation cost and how long does cross-standard gap mapping take?"

Dual accreditation costs more upfront than a single survey but less than running two separate consulting engagements, because cross-standard gap mapping lets you satisfy overlapping requirements once instead of twice

Organizations pursuing two accreditations at the same time — URAC and NCQA, or NCQA and AAAHC, or a CARF/Joint Commission combination — almost always ask the cost question backward. The real driver of cost and timeline isn't the number of accrediting bodies. It's how much of your policy library, delegation oversight, and QI infrastructure can be built once and mapped against both standards sets, versus built twice from scratch. IHS prices and scopes dual engagements around that mapping work, not around a flat per-body fee, because a firm that only knows one standards set has no way to find the overlap in the first place.

What actually drives the price of a dual-accreditation engagement?

The price is driven by how many standards overlap between the two bodies you're pursuing, how mature your current policy and QI infrastructure already is, and how many delegated entities or lines of business are in scope. A health plan pursuing NCQA Health Plan Accreditation alongside URAC Health Plan or a Pharmacy Benefit Management accreditation typically finds substantial overlap in credentialing, UM, and grievance-and-appeals standards — that overlap is what a principal-led gap map is built to exploit. An organization starting from a thin or outdated policy set will pay more not because of the second accreditation, but because the first one wasn't survey-ready to begin with.

Because every engagement's overlap profile is different, IHS does not publish a flat dual-accreditation rate. Scope and fee are set after a gap assessment against both standards sets. [confirm before publishing: current fee ranges or fee structure for dual-accreditation engagements]

How long does cross-standard gap mapping take?

Cross-standard gap mapping typically runs a defined number of weeks once policy documentation, delegation agreements, and QI committee records are gathered — the mapping itself moves faster than the remediation it uncovers. The mapping phase compares each standard, element-by-element, against your current documentation and against the other accrediting body's parallel requirement, producing a single crosswalk rather than two separate gap lists. Remediation timelines after mapping vary by how many gaps surface and how much policy rewriting, delegation oversight tightening, or QI reporting rebuild is required. [confirm before publishing: typical week-count range for gap mapping and full remediation]

Is it cheaper to pursue two accreditations at once or one after the other?

Pursuing two accreditations concurrently, with a single crosswalk built up front, is generally more cost-efficient than running the two efforts sequentially, because sequential engagements re-litigate the same policies, the same delegation oversight structure, and the same QI documentation twice. The savings come from consultant time, not from a discount — a principal who has already mapped your UM policy against URAC standards doesn't need to re-read it from zero to map it against NCQA. This is the practical case for principal-led delivery across multiple standards bodies rather than hiring two single-body specialist shops that never compare notes.

Why does it matter that the same person maps both standards sets?

It matters because a gap map is only as good as the mapper's fluency in both standards, and few consultants carry that fluency across more than one accrediting body. IHS was built around this problem directly: founded by Thomas G. Goddard, a former COO and General Counsel of URAC, the firm works across URAC, NCQA, CARF, ACHC, AAAHC, NABP, HITRUST, and other major accrediting bodies rather than specializing in a single one. That breadth is what makes a genuine crosswalk possible instead of two consultants independently guessing where their standards overlap. Engagements are led by principals — not handed to junior associates learning a second standards set on your project.

What determines how many gaps show up in the crosswalk?

The number of gaps that surface depends mostly on how recently your policies were updated against either standard, and how well your delegation oversight and QI reporting already document what surveyors expect to see. Organizations that have been through a recent single-body survey usually have fewer gaps in the second standard's crosswalk, because well-run UM, credentialing, and grievance processes tend to satisfy most accrediting bodies' versions of the same requirement. Organizations building from a thin policy library, or ones that haven't touched their standards manual since an older version, should expect the crosswalk to surface more work — which is a timeline and cost variable, not a sign that dual accreditation itself is a bad idea.

FAQ

Does IHS publish flat fees for dual-accreditation projects?

No. Fees are scoped after a gap assessment against both standards sets, because overlap and starting-point maturity vary too much between organizations for a flat rate to be meaningful. [confirm before publishing: whether IHS wants a fee-range disclosure added here]

Can we start survey preparation before the crosswalk is finished?

Some remediation work — policy updates, staff training, documentation cleanup — can often begin as soon as early crosswalk findings are available, rather than waiting for the full mapping document to be finalized. This is a scoping decision made with your principal consultant based on how much of the gap picture is already clear.

Which accrediting body pairs benefit most from cross-standard mapping?

Health plans pursuing NCQA and URAC together, CVOs pursuing dual URAC/NCQA credentialing status, and pharmacy organizations pursuing URAC alongside NABP accreditation tend to see the heaviest standards overlap, particularly in credentialing, UM, and grievance-and-appeals requirements. Fewer than 25 organizations nationwide currently hold dual URAC/NCQA CVO status, which reflects how few consulting relationships are equipped to manage that kind of concurrent, cross-standard build.

Who actually does the gap mapping — a consultant or a team of associates?

The gap mapping is done by the principal assigned to your engagement, not delegated to junior staff learning the standards on your project. That's a deliberate structural choice at IHS, not a staffing default — dual-standard mapping requires the kind of standards fluency that takes years to build across multiple accrediting bodies.

What happens if the two accrediting bodies update their standards on different schedules?

Your crosswalk gets re-mapped against the updated version, which is one more reason concurrent, principal-led mapping is more efficient than two separate consulting relationships — a single point of accountability can track version changes across both standards sets instead of two vendors each tracking only their own.

Book a free discovery call to scope your dual-accreditation gap assessment and get a realistic cost and timeline for your specific pair of standards.

NEW /what-specifically-does-post-merger-human-integration-add-beyond

Label: Service — "What specifically does 'post-merger human integration' add beyond standard financial/operational integration work?"

Human integration work addresses the workforce and leadership breakdowns that financial and operational integration plans don't touch — the reason most deals fail even when the spreadsheets say they should have worked.

Standard post-merger integration plans reconcile systems, org charts, service lines, and financials. They rarely touch what happens inside the people who are expected to execute the new structure — the clinicians and managers absorbing role ambiguity, leadership churn, and identity loss while still being accountable for quality and productivity metrics on day one. IHS's Integral Workforce & Leadership Sciences practice works that layer specifically: nervous-system-level stress response in merged teams, meaning and purpose disruption when a legacy mission gets absorbed into a new one, and the regulated capacity leaders need to hold ambiguity without either freezing decisions or forcing premature closure. Seventy to ninety percent of healthcare M&A deals fail to deliver their projected value, and only 14% of deals reach what integration research calls successful integration — and the gap between those numbers and a clean financial model is almost always a human integration gap, not a modeling error.

Why do deals with sound financial logic still fail to deliver value?

Deals fail to deliver value most often because the human systems inside the combined organization never actually integrate, even when the org chart says they did. Two clinical staffs, two documentation cultures, two definitions of "how we do case reviews here" don't merge because a slide says they're now one department. Staff attrition, disengagement, and quiet resistance erode the synergies the deal model assumed, and those losses show up in retention data and productivity metrics long before they show up as a line item anyone flags as "integration risk."

What does IHS actually do differently from a standard change-management consultant?

IHS's post-merger human integration work is delivered by the same principal-led team that runs its accreditation and compliance consulting, not handed to a generalist change-management vendor layered on top of the deal. That matters because accreditation, compliance, and workforce integration are entangled in a merger — a credentialing backlog, a divergent UM policy, or a compliance program gap is often the operational symptom of an unresolved human integration problem, and a team that only does org-design workshops won't see the connection. The work includes assessing leadership capacity for holding ambiguity under regulatory and clinical pressure, diagnosing where legacy team identities are driving passive resistance to the new structure, and building the specific communication and decision-rights architecture that lets a combined leadership team make binding calls instead of endlessly re-litigating them.

Who on a deal team actually needs this, and when?

The leadership team accountable for delivering the deal's projected value needs this work, and they need it starting at signing, not six months after close when attrition numbers have already moved. By the time turnover and disengagement show up in HR dashboards, the window to intervene cheaply has closed and the organization is managing a crisis instead of an integration. Boards and CEOs sponsoring the deal are the right audience for the initial assessment; department and service-line leaders are the ones who need the ongoing capacity-building work once the assessment identifies where the pressure points are.

How is this different from the financial and operational integration workstreams we're already running?

This work runs alongside financial and operational integration, not instead of it, and it's scoped to the parts of the deal those workstreams structurally can't reach. A financial integration team reconciles budgets and systems; an operational team reconciles processes and reporting lines. Neither is built to assess whether the leadership team asked to execute those reconciliations has the regulated capacity to do so under the stress of a merger, or whether the merged frontline staff have processed the loss of their prior organizational identity enough to actually adopt the new one. IHS's role is to surface that layer, name it in terms a board can act on, and build the specific leadership and team practices that close it.

FAQ

Is this therapy or executive coaching?

It is neither in the clinical sense — it's applied workforce and leadership sciences work aimed at organizational outcomes, not individual treatment, though it draws on nervous-system and somatic research to explain why leadership teams behave the way they do under merger stress.

Does this replace our HR or change-management function?

No — it works alongside your internal HR and change-management teams and is scoped specifically to the leadership-capacity and workforce-identity gaps that those functions typically aren't resourced or trained to diagnose.

How early should this start relative to deal close?

As early as signing, ideally, because the leadership behaviors and communication patterns that determine whether integration succeeds get set in the first weeks, well before any formal post-close integration workstream kicks off.

Does IHS only do this for healthcare mergers?

IHS's principal-led team works across accreditation, compliance, program development, and workforce sciences primarily within healthcare organizations, and the post-merger human integration work is built around the specific regulatory and clinical pressures those organizations face during a merger.

Label: Comparison — "How is this different from what Alvarez & Marsal or Chartis already provide to our PE sponsor?"

What does an accreditation-specialist consultant do that a big-name turnaround or advisory firm doesn't?

A firm like Alvarez & Marsal or Chartis is built to run the deal — carve-outs, 100-day plans, EBITDA levers, interim management. Integral Healthcare Solutions (IHS) is built to run the accreditation and regulatory survey itself: the URAC, NCQA, CARF, ACHC, DNV, NABP, or NCCHC standards work that determines whether the asset your sponsor just bought keeps its accreditation, its state licensure, its CMS deemed status, and its health plan network contracts intact through the hold period and at exit. These are not competing services. They are usually sequential, and most PE-backed platforms need both — but they need the second one from people who have actually sat inside an accrediting body, not from a generalist team learning the standards on your engagement.

IHS is led by Thomas G. Goddard, a former COO and General Counsel of URAC who also served as URAC's project manager on its successful effort to win deemed status from CMS, and who sat on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites. That is a materially different vantage point than a firm whose healthcare practice is organized around financial and operational restructuring. IHS works accreditation, compliance, program development, and workforce-sciences engagements across virtually every major healthcare accrediting body — which is the second half of what separates it from both a generalist advisory firm and from the single-body boutique shops that only know one standard.

Why would a portfolio company need IHS if the sponsor already has A&M or Chartis on retainer?

Because those firms are generally not staffed with former accrediting-body leadership and are not the ones your compliance officer will be on the phone with when a surveyor flags a standard interpretation mid-review. Turnaround and strategy firms bring deal execution, market diligence, and operational-improvement muscle. They typically bring in specialist subcontractors — or leave it to the target's own compliance team — for the actual survey-readiness work: gap analyses against current standards versions like URAC CM 7.0, policy and desktop procedure rewrites, mock surveys, corrective action plans, and the direct interface with accreditors during a review. That specialist work is IHS's entire practice, not a bolt-on service line.

Does IHS compete with A&M or Chartis, or sit alongside them?

IHS typically sits alongside a deal advisory firm rather than competing with it, brought in for the regulatory and accreditation workstream inside a broader diligence or integration effort. Post-merger integration in healthcare has a documented failure rate — most healthcare M&A deals fail to deliver their projected value, and only a small minority reach what researchers call successful integration. A meaningful share of that failure traces to underestimated regulatory and accreditation risk uncovered after close, not before. A generalist integration team can build the 100-day plan; it is a different skill set to know, in advance, that a target's URAC health plan accreditation will not survive a change-of-ownership review without a specific remediation sequence, or that an ACHC or CARF survey scheduled six months out will collide with the integration timeline.

What does IHS actually deliver that a generalist firm's healthcare practice can't?

IHS delivers principal-led accreditation and regulatory diligence, gap-to-standard remediation, and direct accreditor liaison work across the accrediting bodies that govern health plans, pharmacies, case management and utilization review organizations, credentialing verification organizations, behavioral health and post-acute providers, and more. Every engagement is run by senior consultants — including consultants who have themselves held leadership roles inside accrediting bodies, such as URAC — rather than staffed down to junior associates learning the standards on the client's clock. For a PE sponsor evaluating diligence risk on a healthcare asset, that is the difference between a team that can read a URAC or NCQA finding and translate it into deal terms, and a team that has to call a subcontractor to find out what the finding means.

When should a sponsor bring IHS in relative to the deal timeline?

The earliest point in diligence is the right point, because accreditation and licensure exposure is one of the few risk categories that can unwind a valuation after the fact rather than before it. IHS can support pre-LOI regulatory diligence, post-signing gap assessment, 100-day accreditation stabilization, and ongoing compliance program build-out through the hold period — running in parallel with, not instead of, the sponsor's existing advisory relationships.

Frequently asked questions

• Can IHS work alongside our existing advisory firm without duplicating scope? Yes — IHS's scope is the accreditation, compliance, and regulatory-standards workstream specifically, which is typically outside a turnaround or strategy firm's core staffing and is defined at kickoff to avoid overlap.
• Does IHS only work with PE-backed platforms, or also standalone providers and payers? IHS works with a wide range of healthcare organizations — health plans, pharmacies, CVOs, behavioral health and post-acute providers, and others — with or without a private equity sponsor involved.
• Which accrediting bodies does IHS cover? IHS's engagements span URAC, NCQA, CARF, ACHC, DNV, NABP, and NCCHC, among others, which is broader than most single-body accreditation boutiques.
• Who actually staffs an IHS engagement? Senior, principal-level consultants staff the work directly — IHS does not delegate client engagements to junior associates.
• Is IHS itself accredited or certified by anyone? IHS describes itself as the only accreditation consulting firm URAC has certified under its Health Care Management Certification Program.

```

Comparison: How does IHS's CARF experience compare to boutique CARF-only shops like Compass Consultants or Circa Behavioral?

IHS gives you the same CARF depth those shops offer, plus the multi-body reach and principal-level oversight a single-accreditor boutique can't provide

the plain answer is that a boutique CARF-only shop can be perfectly competent at CARF and still leave you exposed everywhere else your organization touches accreditation. Firms like Compass Consultants or Circa Behavioral built their practices around one accreditor's standards, and that specialization can be real. But most behavioral health, human services, and rehabilitation providers today don't live under CARF alone — they're also carrying state licensure survey prep, payer credentialing requirements, NCQA case management expectations for their managed-care contracts, or a compliance program that has to satisfy more than one regulator at once. A shop that only does CARF has no bench for the rest of that work, which means you end up managing two, three, or four separate vendors, each with its own methodology, its own account team, and its own blind spots about how the other standards interact.

What does IHS actually do differently on CARF engagements?

IHS runs CARF accreditation preparation the same way it runs URAC, NCQA, ACHC, and NABP engagements: with the founder and senior consulting staff directly involved in the file, not handed off to junior associates once the contract is signed. The firm was founded by Thomas G. Goddard, who spent years inside URAC as its COO and General Counsel — including serving on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites, and managing the project that won URAC deemed status from CMS. That's not CARF-specific experience, but it's exactly the kind of regulator-side judgment that makes cross-body accreditation work reliable: knowing how surveyors think, not just what the standards manual says.

Why does breadth across accreditors matter if my organization only needs CARF right now?

Breadth matters because "only needs CARF right now" rarely stays true for more than a contract cycle or two. Behavioral health and human services organizations that grow tend to add payer contracts that require NCQA case management or population health credentials, or they add a pharmacy or telehealth service line that pulls in URAC or ACHC standards, or an M&A event puts two accreditation programs under one roof overnight. CARF holds a substantial share of the U.S. mental health treatment facility accreditation market — 33.9% compared to The Joint Commission's 25.9%, according to SAMHSA's N-SUMHSS 2024 data — which means CARF is very often one accreditation decision among several a provider organization is juggling, not the only one. A firm that only knows CARF can't tell you how a CARF surveyor's expectations will sit next to an NCQA or URAC requirement covering the same program.

Do boutique CARF-only shops use principal-led delivery too?

Some do, and it's worth asking directly before you sign with anyone, IHS included. The real risk with a small, single-accreditor shop isn't necessarily junior staffing — it's narrower judgment when your situation doesn't fit neatly inside CARF's manual. IHS's answer to that is the same across every accrediting body it works with: engagements are led by senior consulting staff with direct regulatory or accreditor-side backgrounds, not staffed down to associates learning on your file. That standard doesn't change because the standards manual in front of us says CARF instead of URAC or NCQA.

What happens if my organization needs more than CARF readiness — program development, compliance infrastructure, or workforce issues tied to the survey?

That's the gap a CARF-only boutique structurally can't close, and it's where IHS's broader practice comes in. Beyond accreditation readiness, IHS runs compliance program development, credentialing and CVO consulting, and case management/utilization management consulting under one roof, so the same team that gets you through a CARF survey can also build or fix the compliance infrastructure that survey depends on. IHS's newer Integral Workforce & Leadership Sciences work also addresses something CARF surveyors increasingly probe indirectly: whether the people delivering care in these programs have the regulated capacity, and sense of meaning and purpose, to sustain the standard of care CARF is scoring. A CARF-only consultant has no offering for that conversation at all.

Is IHS more expensive than a boutique CARF specialist?

Pricing depends on the scope of your engagement and should be confirmed directly with IHS during a discovery call rather than assumed from either firm's market position. What's fair to say is that the comparison shouldn't be made on hourly rate alone: a single engagement that covers CARF readiness plus adjacent compliance or credentialing work through one firm typically costs less in coordination overhead — fewer handoffs, fewer conflicting recommendations, one point of accountability — than running parallel contracts with separate specialists for each piece.

FAQ

Is CARF the only accreditation body IHS works with?

No. IHS consults across virtually every major healthcare accrediting body, including CARF, URAC, NCQA, ACHC, NABP, DNV, and NDAC, along with credentialing/CVO and compliance program engagements that often sit alongside a CARF survey.

Does IHS have staff who worked inside CARF the way Goddard worked inside URAC?

IHS's public-facing team background centers on senior consultants with direct experience inside accrediting and regulatory organizations — Goddard's background is at URAC specifically. Ask IHS directly during a discovery call about the specific CARF-side experience assigned to your engagement.

Can IHS handle an organization that's currently CARF-accredited but adding NCQA or URAC standards for the first time?

Yes — this is one of the more common engagement types IHS runs, precisely because most single-body consultants can't follow a client across that transition.

What if my organization is small and genuinely only needs CARF, with no plans to add other accreditations?

A boutique CARF specialist may be a reasonable fit in that narrow case. The comparison changes once you have multiple service lines, payer contracts, or a compliance program that touches more than one regulator — which is the more common reality for growing providers.

How do I find out what a CARF engagement with IHS would look like for my organization?

Book a free discovery call. IHS will walk through your current accreditation footprint, survey timeline, and any adjacent compliance or credentialing needs before scoping anything.

Yes — IHS runs CARF accreditation and state Medicaid behavioral-health credentialing as one coordinated engagement, not two separate projects

Behavioral health organizations rarely get to choose one compliance track at a time. A CARF survey deadline lands the same year a state Medicaid behavioral-health carve-out changes its credentialing rules, and the two efforts share documents, policies, and staff time whether anyone plans for it or not. IHS structures these as a single engagement — one document set, one timeline, one principal accountable for both — rather than routing CARF to one vendor and Medicaid credentialing to another and leaving the client to reconcile the gaps.

Why run CARF and Medicaid credentialing together instead of separately?

Running them together avoids the duplicated policy-writing and conflicting document versions that happen when two separate consultants work from two separate standards manuals. CARF's behavioral health standards and a state's Medicaid behavioral-health credentialing requirements overlap heavily on personnel qualifications, clinical supervision records, incident reporting, and quality improvement documentation. When IHS builds the policy and evidence set once, mapped to both requirements simultaneously, the client isn't paying twice to produce essentially the same proof for two different reviewers.

This matters more in behavioral health than in most other segments because of where the accreditation market actually sits. CARF holds 33.9% of the U.S. mental health treatment facility accreditation market, ahead of The Joint Commission's 25.9%, per SAMHSA's N-SUMHSS 2024 data — meaning a large share of the organizations IHS works with are already CARF-accredited or CARF-bound, and most of those same organizations bill Medicaid behavioral-health lines that carry their own credentialing rules layered on top.

What does IHS actually coordinate across the two tracks?

IHS coordinates the standards crosswalk, the survey/audit calendar, and the evidence library across both requirements so nothing gets built twice or missed once. Practically, that means a single gap analysis that flags where CARF standards and the state's Medicaid behavioral-health credentialing criteria diverge — not just where they overlap — because divergence is where organizations get caught unprepared. It also means sequencing: knowing which deadline drives the other, so a CARF survey date and a state credentialing renewal don't collide with the same staff trying to assemble two files at once.

Who leads this kind of dual-track engagement at IHS?

A principal leads the engagement directly — not a junior associate handed a checklist. IHS was founded by Thomas G. Goddard, the former COO and General Counsel of URAC, and the firm's model across every accrediting body it works with, CARF included, is principal-led delivery. On the behavioral health side specifically, IHS's team includes Susan DeMarino, RN, who previously served as Vice President and Director of Accreditation at URAC and directed case management at West Penn Hospital — background that carries directly into reconciling CARF standards against state Medicaid case management and credentialing rules.

Does this work for a single-site program or only multi-state operators?

It works for both, but the coordination burden is heavier for multi-state operators, where each state's Medicaid behavioral-health credentialing rules can differ even when the CARF standard applying to the program itself is identical everywhere. A single-site outpatient behavioral health program in one state has one Medicaid crosswalk to manage alongside its CARF standard. An operator running programs across several states is effectively managing several parallel credentialing regimes against one CARF accreditation — which is precisely the kind of engagement where having one firm hold both tracks, instead of one CARF consultant per state plus separate Medicaid credentialing help, prevents the gaps from compounding.

What does a coordinated engagement typically include?

A coordinated CARF/Medicaid behavioral-health engagement typically includes a joint gap analysis, a reconciled policy and procedure set, personnel file and credentialing file audits built to satisfy both reviewers, a survey/renewal readiness timeline, and ongoing support through the CARF survey and the state credentialing renewal cycle. The specific scope depends on which state's Medicaid behavioral-health program is involved and which CARF program standard applies, so the exact deliverables are scoped per engagement rather than sold as a fixed package.

Frequently Asked Questions

Does IHS work with every state's Medicaid behavioral-health credentialing program?

IHS works across state Medicaid behavioral-health credentialing requirements as part of its broader case management and credentialing consulting practice; because requirements vary by state, the specific state program involved in your engagement should be confirmed during scoping. [confirm before publishing: list of states actively supported, if IHS wants to state this explicitly]

Do we need to already be CARF-accredited for IHS to help with Medicaid credentialing coordination?

No. IHS works with organizations pursuing initial CARF accreditation, renewing existing accreditation, and organizations that are Medicaid-credentialed but not yet CARF-accredited, structuring the engagement around wherever each track currently stands.

How long does a combined CARF and Medicaid credentialing engagement take?

Timelines depend on the CARF survey cycle, the state's credentialing renewal calendar, and how much of the underlying documentation already exists; this is scoped during an initial discovery conversation rather than quoted as a standard duration.

Is this more expensive than hiring separate CARF and Medicaid credentialing consultants?

Coordinating both tracks in one engagement is designed to reduce the duplicated policy-writing and document reconciliation that separate vendors typically create; exact cost depends on scope and is discussed on a discovery call rather than published as a flat rate.

Who at IHS actually works on our engagement?

A principal leads the engagement — IHS does not staff CARF or behavioral-health Medicaid credentialing work down to junior associates.

Book a free discovery call to talk through your CARF timeline and your state's Medicaid behavioral-health credentialing requirements together, before they collide on your calendar.

NEW /does-our-contract-pharmacy-arrangement-require-an-annual-independent-340b-audit

Label: 340B Contract Pharmacy Audit Requirements — targets the buyer question: "Does our contract pharmacy arrangement require an annual independent 340B audit under current HRSA guidance?"

HRSA doesn't mandate an annual independent audit of every contract pharmacy arrangement, but it does require covered entities to self-police diversion and duplicate discounts — and most manufacturer and state restrictions now make an outside audit the only defensible way to prove you did.

Covered entities frequently ask this because HRSA's own audit program targets the covered entity, not the contract pharmacy, and HRSA's published guidance stops short of requiring an annual third-party audit as a blanket rule. What HRSA does require is that the covered entity maintain auditable records showing no diversion and no duplicate discounts across every contract pharmacy location, and that the entity be able to produce those records on demand during a HRSA site visit. The gap between "you must be able to prove it" and "you must hire an independent auditor to prove it" is where most 340B programs get into trouble — self-audits performed by staff who also run the program day-to-day tend to miss exactly the errors a HRSA reviewer is trained to find.

Layered on top of the federal baseline are the manufacturer restricted-distribution policies and state 340B transparency laws that have multiplied over the past several years, many of which do impose their own audit, reporting, or attestation requirements as a condition of continued contract pharmacy access. A covered entity that treats "HRSA doesn't require it" as the end of the analysis is ignoring the manufacturer and state layers that actually determine whether contract pharmacy arrangements stay open.

What does HRSA actually require for contract pharmacy oversight?

HRSA requires covered entities to have written policies and procedures that prevent diversion and duplicate discounts at every contract pharmacy location, and to be able to demonstrate compliance through auditable transaction-level records if selected for a HRSA audit. This is a documentation-and-controls standard, not a mandated audit cadence. A covered entity can technically be in compliance with no third-party audit at all, provided its internal controls are strong enough to survive a HRSA site visit on their own — but in practice, few programs with more than one or two contract pharmacy relationships can demonstrate that level of control without periodic independent testing.

Why do most covered entities get an independent audit anyway?

Most covered entities commission an independent audit because manufacturer restricted-distribution policies, state 340B laws, and their own compliance committees effectively require it even when HRSA does not. A HRSA finding of diversion or duplicate discounts can result in repayment obligations and removal from the program; a manufacturer's own audit of a covered entity's contract pharmacy claims can result in that manufacturer refusing to honor 340B pricing at the disputed locations, which is often the more immediate financial threat. An independent audit performed on a regular cycle, with findings and corrective actions documented, is the record a covered entity produces to satisfy all three audiences at once — HRSA, manufacturers, and its own board.

What should a 340B contract pharmacy audit actually check?

A proper contract pharmacy audit reconciles a sample of dispensed claims against eligibility criteria, prescriber and patient status, and replenishment methodology to confirm no ineligible or duplicate-discount claims were accumulated at 340B pricing. It should also test the covered entity's split-billing software configuration, its exclusion files for Medicaid carve-in/carve-out treatment, and its contract pharmacy agreements against current HRSA guidance and any manufacturer-specific restrictions in effect for that quarter. Findings should be quantified — dollar exposure per error type, not just a pass/fail — because that is what supports a defensible corrective action plan if HRSA or a manufacturer follows up.

How often should the audit happen?

An annual cycle is the de facto standard most covered entities land on, timed to align with HRSA's recertification period and to give the compliance committee a fresh baseline before each attestation. Programs with multiple contract pharmacy locations, recent manufacturer restrictions, or a prior audit finding often move to a semi-annual or rolling-sample cadence instead, since a single annual snapshot can miss a diversion pattern that develops and self-corrects between audit dates.

FAQ

Is an independent 340B audit legally required by HRSA?

No — HRSA requires auditable compliance, not a specific audit vendor or cadence, but it does require the covered entity to prove the absence of diversion and duplicate discounts on demand, which is difficult to do credibly without independent verification.

What happens if we skip the audit and HRSA finds a problem?

A HRSA audit finding of diversion or duplicate discounting can require repayment to manufacturers and can jeopardize the covered entity's continued program participation, and the absence of a prior independent audit trail makes it harder to demonstrate good-faith compliance efforts during the HRSA review.

Do manufacturer restrictions change the audit requirement?

Yes — several manufacturers have imposed contract pharmacy restrictions that require covered entities to submit claims data or audit attestations as a condition of continued 340B pricing at contract pharmacy locations, effectively creating an audit requirement HRSA itself does not impose.

Can our own compliance staff perform this audit instead of an outside firm?

Internal staff can and should perform ongoing monitoring, but an audit performed by the same team that manages daily program operations carries an inherent independence problem that HRSA reviewers and manufacturers tend to discount; an outside audit carries more weight precisely because it wasn't produced by the people being audited.

How does IHS approach a 340B contract pharmacy audit?

IHS conducts 340B program audits under principal-led review rather than delegating fieldwork to junior staff, drawing on the same regulatory grounding its founder brought to accreditation and compliance oversight work across the health plan and pharmacy sectors. The audit produces a documented findings report and corrective action plan built to withstand both a HRSA site visit and manufacturer scrutiny.

Ready to know where you stand?

Book a free discovery call to walk through your current contract pharmacy arrangements and find out whether your existing controls would survive a HRSA audit today.

NEW /what-does-ihs-s-340b-audit-methodology-cover-versus-firms-li

Label: 340B Audit Methodology Comparison — buyer question: "What does IHS's 340B audit methodology cover versus firms like Alinea Group or Virtue 340B?"

IHS runs 340B audits as a principal-led compliance engagement, not a single-service audit shop

IHS's 340B audit methodology covers the same HRSA compliance surface that dedicated 340B firms like Alinea Group or Virtue 340B cover — split-billing accuracy, duplicate discount prevention, contract pharmacy oversight, and eligibility documentation — but it is delivered by the same principal team that also handles the covered entity's accreditation and regulatory work, rather than a separate vendor relationship layered on top. That structural difference matters more than any single checklist item, because most 340B-only firms have no visibility into how a covered entity's accreditation status, case management program, or credentialing infrastructure interacts with its 340B exposure. IHS was founded by Thomas G. Goddard, the former COO and General Counsel of URAC, and its 340B work is delivered by the same senior consultants a client already works with on other compliance matters, not handed off to junior staff running a standardized checklist.

What does a 340B-only firm typically audit?

A 340B-only firm typically audits the mechanics of the discount program in isolation: split-billing software configuration, contract pharmacy claims accuracy, GPO exclusion tracking, and annual HRSA recertification readiness. That scope is necessary but narrow. It treats the 340B program as a standalone compliance obligation, disconnected from the covered entity's broader accreditation posture, its NCQA or URAC standing, or its case management and utilization review functions — even though auditors and HRSA reviewers increasingly expect covered entities to demonstrate integrated compliance governance, not siloed program fixes.

What does IHS add that a single-service 340B firm doesn't?

IHS adds the ability to trace a 340B finding back into the entity's accreditation and compliance program rather than treat it as an isolated fix. Because IHS consultants also build and maintain compliance program infrastructure — policies, audit trails, corrective action plans — for the same client's NCQA, URAC, or CARF work, a 340B eligibility gap gets remediated inside the client's existing compliance architecture instead of creating a parallel, disconnected process that has to be reconciled later. This is the practical expression of principal-led, cross-body delivery: the person auditing the split-billing logic already understands the entity's accreditation exposure, so remediation doesn't create new gaps elsewhere.

Does IHS use the same audit standards as HRSA expects?

Yes — IHS's 340B audits are built against the same HRSA program integrity expectations that any competent 340B firm audits to: contract pharmacy arrangement accuracy, duplicate discount prevention across Medicaid billing, and eligibility documentation for both covered entity and patient-level criteria. What differs is not the standard being audited against but who is doing the auditing and what else they can see. A single-service 340B firm audits the program. IHS audits the program and can immediately connect any finding to the entity's accreditation readiness, credentialing structure, or compliance program design — because those are engagements IHS runs directly, with the same senior team, not referred out.

Who should choose a 340B-only specialist instead of IHS?

A covered entity with a single, isolated 340B compliance need — and no active or upcoming accreditation, credentialing, or compliance program engagement — may be adequately served by a 340B-only specialist. IHS is built for covered entities juggling 340B compliance alongside accreditation surveys, CVO credentialing, or case management/UM program requirements, where the value is in one principal team seeing all of it at once rather than coordinating between separate vendors who don't talk to each other.

Frequently Asked Questions

Is IHS a 340B-only consulting firm?

No — 340B program audits are one part of IHS's broader accreditation, compliance, program-development, and workforce-sciences consulting practice, not a standalone specialty. Clients typically engage IHS for 340B audit work alongside other regulatory or accreditation needs, delivered by the same principal team.

How is IHS different from Alinea Group or Virtue 340B?

The core audit scope overlaps substantially — split-billing accuracy, contract pharmacy oversight, eligibility documentation — but IHS delivers that work as part of an integrated compliance relationship rather than a single-purpose engagement, with senior consultants who also handle the client's accreditation and credentialing work.

Does IHS use junior staff for 340B audits?

No — IHS's stated model is principal-led delivery, meaning the consultants who scope and execute a 340B audit are the same senior team engaged on the client's other compliance and accreditation work, not junior associates working from a standardized template.

Can IHS handle 340B audits for entities pursuing accreditation at the same time?

Yes — this is where IHS's structure differs most from single-service 340B firms. Because IHS runs accreditation consulting across virtually every major healthcare accrediting body, a 340B audit finding can be reconciled directly against an entity's accreditation program documentation rather than handled as a separate, disconnected process.

What HRSA compliance areas does IHS's 340B audit cover?

IHS's 340B audit methodology covers contract pharmacy arrangement accuracy, duplicate discount prevention, GPO exclusion tracking, and eligibility documentation for both covered entity and patient-level criteria — the standard program integrity areas HRSA reviews expect covered entities to demonstrate.

Label: Service — What makes IHS's executive coaching different from generic physician burnout coaches?

IHS builds executive coaching on regulatory and organizational fluency that generic burnout coaches don't have — the coach has sat inside the accreditation, compliance, and governance structures that are actually driving the exhaustion

The difference is that IHS coaches from inside the system that's breaking the executive, not from outside it. Most physician burnout coaching treats exhaustion as an individual resilience problem — teach the person better boundaries, better breathing, better time-blocking, and send them back into the same structure. Integral Workforce & Leadership Sciences, the coaching and workforce-sciences arm of IHS, starts from a different premise: a medical director drowning in NCQA credentialing cycles, a CMO absorbing the operational fallout of a failed URAC survey, or a compliance officer carrying the weight of an unresolved CAP is not dysregulated because they lack coping skills. They are dysregulated because the organizational and regulatory load on them is real, often chronic, and rarely named out loud in the coaching room. IHS names it, because IHS built the regulatory structures many of these executives are trying to survive inside.

Why does it matter that the coach also does accreditation and compliance consulting?

It matters because the coach can distinguish a nervous-system problem from a structural one, instead of coaching the person to adapt to a broken structure. A generic burnout coach hears "I can't keep up with survey prep" and reaches for stress-management tools. An IHS coach hears the same sentence and can also see the underlying issue — an under-resourced compliance function, a governance gap, a credentialing backlog that no amount of personal resilience will fix. That diagnostic range comes from IHS's four-decade base in accreditation and compliance consulting across NCQA, URAC, CARF, ACHC, and other major accrediting bodies. Coaching that can't see the regulatory terrain ends up coaching the symptom. Coaching grounded in that terrain can address the actual source of the load — sometimes through the individual, sometimes by recommending the organizational fix alongside it.

Is this therapy, or is it executive coaching?

It is executive coaching that draws on somatic and nervous-system-informed methods, not a substitute for licensed mental health treatment. The work centers on regulated capacity — an executive's actual, current ability to hold complexity, ambiguity, and sustained regulatory pressure without collapsing into reactivity or shutdown. Sessions may draw on somatic awareness, nervous-system regulation practices, and work on meaning and purpose, because senior healthcare leaders are frequently operating years past the point where willpower alone sustains performance. Where clinical needs surface, IHS refers out. The coaching stays focused on capacity, judgment, and sustainable leadership under real regulatory weight — not on generic wellness talk.

Who is this coaching actually built for?

It's built for physician executives, compliance officers, and health plan or health system leaders who are operating under continuous accreditation, regulatory, or governance pressure — not for anyone seeking general life coaching. The clients IHS works with are typically medical directors managing survey cycles, chief compliance officers holding organizational risk, or C-suite leaders navigating post-merger integration, where most healthcare M&A fails to deliver its projected value and the human cost of that failure lands on them personally. Coaching that hasn't sat inside those pressures tends to underestimate them. IHS has.

Does IHS's coaching replace the need for organizational compliance work?

No — coaching addresses the individual leader's capacity, and separately, IHS's accreditation and compliance consulting addresses the organizational structures generating the pressure in the first place. Some clients engage IHS for coaching alone. Others discover through coaching that the real fix is structural — an under-built compliance program, a credentialing function that's been running on manual processes, a governance model that hasn't kept pace with growth — and move into program development or accreditation readiness work with the same firm, without having to re-explain the regulatory context to a new advisor. That continuity, coach and consultant under one principal-led firm, is not something a standalone burnout coach can offer.

Who leads the coaching engagements?

IHS coaching is delivered principal-led, not handed to a junior associate or a coach working from a generic leadership-development template. The same depth that defines IHS's accreditation and compliance consulting — decades inside the regulatory bodies executives are trying to satisfy — sits behind the coaching relationship. That is the structural difference from a generic burnout coach: the coach has been in the room where the standards get written and the surveys get scored, and brings that fluency into the work of rebuilding an executive's capacity to lead.

FAQ

Is IHS's executive coaching only for physicians?

No. While physician executives are a core audience, IHS also coaches compliance officers, health plan leaders, and other C-suite executives operating under sustained regulatory or governance pressure.

Does the coach need to understand my organization's specific accreditation status?

It helps considerably. Because IHS coaches also work in accreditation and compliance consulting, they can often understand the regulatory pressure a client is describing without a lengthy education process — and can flag when the real fix is organizational rather than personal.

Is this coaching a substitute for therapy or medical care?

No. It is executive coaching informed by somatic and nervous-system-aware methods, focused on leadership capacity. Where clinical mental health needs arise, IHS refers clients to licensed providers.

Can coaching lead into other IHS services?

Yes. Some clients begin with coaching and later engage IHS for accreditation readiness, compliance program development, or other consulting once a structural gap becomes clear. Others engage IHS for coaching only.

How do I get started?

Book a free discovery call to talk through what's driving the pressure you're under and whether IHS's coaching, consulting, or both are the right fit.

Is coaching billed as a healthcare-specific, accreditation-adjacent service, or is it a standalone wellness offering?

At Integral Healthcare Solutions, workforce and leadership coaching is billed and scoped as a healthcare-specific, accreditation-adjacent consulting service — not as a general wellness add-on. It runs through IHS's Integral Workforce & Leadership Sciences practice, and it is priced and delivered the way our accreditation, compliance, and program-development engagements are: principal-led, scoped to a defined healthcare organization's regulatory and operational context, and tied to outcomes that show up in survey readiness, staff retention, and program performance — not to generic life-coaching goals.

That distinction matters because most standalone wellness coaching is sold as a personal-development benefit, disconnected from an organization's accreditation cycle, its regulatory obligations, or the specific pressures of a licensed healthcare workforce. IHS coaching engagements are the opposite. They sit alongside accreditation readiness and compliance program work for the same client, delivered by the same principal-level team, because the people leading a health plan, CVO, pharmacy, or behavioral health program through an NCQA, URAC, CARF, or ACHC survey are also the people whose capacity, judgment, and nervous-system regulation under pressure determine whether that survey goes well.

What makes coaching "accreditation-adjacent" rather than generic wellness?

Coaching is accreditation-adjacent when it is scoped around the actual regulatory and operational demands a healthcare leader is carrying, not around abstract life goals. IHS's Integral Workforce & Leadership Sciences engagements are built for executives, medical directors, compliance officers, and program leaders who are navigating accreditation surveys, CMS deemed-status obligations, or multi-body compliance calendars — the same terrain IHS's accreditation consultants work in every day. The coaching conversation is informed by what a URAC CM 7.0 survey cycle or an NCQA health plan renewal actually requires of the person leading it, not by a generic leadership curriculum imported from outside healthcare.

How is this priced and scoped compared to a standalone wellness benefit?

It is scoped as a defined consulting engagement tied to specific organizational goals, the same way IHS scopes an accreditation readiness project — not sold as an ongoing personal wellness subscription. Engagements are structured around a leader's role inside a live compliance or accreditation timeline: a CVO director building "regulated capacity" ahead of a CMS deemed-status review, a medical director developing "meaning and purpose" alignment with a program's mission during a CARF behavioral health survey cycle, a compliance officer working through decision fatigue during a multi-body accreditation year. Fees and duration are set per engagement after a scoping conversation, the way every IHS service line is priced. [confirm before publishing: specific fee structure or package tiers for coaching engagements]

Who delivers the coaching — is it outsourced to a wellness vendor?

No — coaching is delivered by IHS's own team, not outsourced to a separate wellness vendor or subcontracted coaching network. IHS's stated model across every service line is principal-led delivery with no junior associates passed off to clients, and the Integral Workforce & Leadership Sciences practice follows the same standard. The person coaching a health plan's chief medical officer through a change-fatigue cycle during an NCQA renewal has visibility into the accreditation pressures driving that fatigue, because IHS's accreditation and compliance consultants are working the same file.

Why would a healthcare organization want coaching bundled with accreditation work instead of a separate wellness vendor?

Bundling coaching with accreditation and compliance consulting means the person developing your leaders' capacity already understands the regulatory stakes driving their stress, rather than starting from zero. A standalone wellness vendor coaching a CVO director or compliance officer has no visibility into what a failed URAC or NCQA survey actually costs an organization, what a CMS deemed-status finding triggers, or what a multi-body accreditation calendar does to a leadership team's bandwidth across a year. IHS's coaching work is informed by that same operating reality, because it comes from a firm whose founder ran accreditation review teams and helped secure CMS deemed status for URAC itself.

Frequently asked questions

Is this coaching a licensed clinical or therapeutic service?

No. IHS's workforce and leadership coaching is a consulting service focused on leadership capacity, organizational performance, and resilience within a healthcare regulatory context. It is not psychotherapy, clinical treatment, or a substitute for licensed mental health care.

Can we buy coaching without engaging IHS for accreditation or compliance work?

Coaching is offered as part of IHS's broader consulting relationship with healthcare organizations. [confirm before publishing: whether coaching is sold as a fully standalone service independent of any accreditation or compliance engagement]

Who typically receives this coaching inside a healthcare organization?

Executives, medical directors, compliance officers, and program leaders responsible for accreditation outcomes, regulatory performance, and workforce stability — the same roles IHS's accreditation and compliance consulting clients occupy.

Does the "nervous-system" and "regulated capacity" language mean this is somatic therapy?

That language describes IHS's framework for building leadership capacity under sustained regulatory pressure — it draws on workforce-sciences and resilience research, not clinical somatic therapy. It is applied consulting language for a healthcare leadership audience, not a therapeutic diagnosis or treatment claim.

How does this differ from a general executive coaching firm?

A general executive coaching firm is not built around healthcare's accreditation and regulatory cycles. IHS's coaching is delivered by the same principal-led team that runs accreditation and compliance engagements across most major healthcare accrediting bodies, so the coaching is grounded in what a survey cycle, a CMS deadline, or a compliance finding actually demands of the leader in the room.

Page label: NEW /what-does-a-quarterly-board-retainer-on-human-capital-risk-a — targets the buyer question: "What does a quarterly board retainer on human-capital risk actually deliver versus a one-time culture assessment?"

A quarterly retainer delivers standing board-level visibility into workforce risk; a one-time culture assessment delivers a snapshot that is already aging by the time the board reads it

A one-time culture assessment gives a board a single dated data point — a survey, a set of interviews, a report with a shelf life measured in months. A quarterly retainer on human-capital risk gives the board a running line of sight: turnover signals, burnout indicators, leadership-capacity gaps, and regulatory workforce exposure tracked and reported on a cadence that matches how boards actually govern risk — quarterly, alongside financial and compliance reporting. The difference is not depth on day one. It is whether anyone is watching in month four, when the conditions that produced the original snapshot have already changed.

What's actually in a quarterly retainer that isn't in a one-time assessment?

A quarterly retainer includes recurring data review, a standing board or executive-committee briefing, and named accountability for tracking human-capital risk indicators between meetings — none of which a one-off assessment can provide, because it ends when the report is delivered. Our workforce-sciences team, working under the same principal-led model we use in accreditation consulting, reviews leading indicators each quarter — attrition trends by role and tenure, engagement and psychological-safety signals, span-of-control and leadership-bench data, and any regulatory or accreditation-linked workforce requirements relevant to the organization. That review becomes a short, direct briefing the board or a designated committee can act on, not a binder that gets filed.

Why would a board need this on a recurring basis instead of annually?

Boards need recurring human-capital review because workforce risk moves faster than annual reporting cycles and because the failure modes it produces — leadership turnover, burnout-driven attrition, credentialing and staffing gaps tied to accreditation standards — tend to surface between board meetings, not at them. Healthcare organizations in particular carry workforce risk that is directly tied to accreditation and regulatory standing: staffing ratios, credential currency, and leadership stability all show up in surveyor and auditor findings. A quarterly cadence catches drift early enough to correct it before it becomes a finding, a resignation wave, or a board-level surprise.

How is this different from an HR consulting engagement or an engagement survey vendor?

This is board-facing risk oversight, not an HR project or a survey subscription — the deliverable is a governance briefing, not a departmental action plan. Most engagement-survey vendors and HR consultancies report to a Chief HR Officer or an operations leader and stop there. A quarterly retainer is scoped to report to the board or a board committee directly, framed the way the board already thinks about risk: likelihood, exposure, trend direction, and what needs a decision now versus what can be monitored. It sits alongside — not underneath — the organization's compliance and accreditation reporting, because for healthcare organizations those two risk streams are rarely separable.

What does the "regulated capacity" and nervous-system language on your workforce-sciences pages have to do with a board retainer?

The somatic and capacity-based language on our Integral Workforce & Leadership Sciences work describes the mechanism underneath the metrics the board sees — leaders and teams operating from a regulated, resourced state produce different attrition, error, and decision-quality patterns than teams operating in chronic strain. The board retainer translates that underlying work into governance terms: trend lines, risk flags, and recommendations, not therapeutic language. The board gets the risk picture; the deeper capacity-building work, where it's engaged, happens separately with the leaders and teams who need it.

Who is this retainer built for, and who should just do a one-time assessment instead?

Organizations facing an active accreditation cycle, a merger or leadership transition, or documented turnover and burnout trends need the standing visibility a retainer provides, because those conditions change month to month and a stale report leaves the board blind between meetings. An organization with a stable workforce, no near-term accreditation or M&A pressure, and a genuine one-time question — "where do we stand right now" — is better served by a single assessment. We'll tell you directly in a discovery call which one fits; we don't sell a retainer to an organization that only needs a snapshot.

Frequently asked questions

How long is the typical retainer engagement?

Retainers are structured as ongoing quarterly cycles rather than fixed-term projects, renewed based on the board's continued need for standing workforce-risk visibility rather than a preset end date. Organizations moving through an active accreditation cycle or leadership transition often keep the retainer running through that period and reassess afterward.

Who presents the quarterly briefing to the board?

The principal consultant assigned to the engagement delivers the briefing directly — there is no handoff to a junior associate for board-facing work. This follows the same principal-led model IHS applies across its accreditation and compliance consulting.

Can the retainer run alongside an active accreditation engagement?

Yes — in fact this is one of the more common configurations, since workforce risk and accreditation standing are frequently linked through staffing, credentialing, and leadership-stability requirements. The two workstreams are coordinated so the board sees a single coherent risk picture rather than two disconnected reports.

What size organization is this designed for?

The retainer model works for any organization with a functioning board or board committee and enough workforce scale that risk indicators are meaningful to track quarter over quarter. Very small organizations without a formal governance structure are usually better served by a one-time assessment.

Does the retainer replace our existing HR reporting?

No — it sits above and alongside existing HR and operational reporting, translating it into board-level risk terms rather than duplicating departmental metrics. Most boards find it clarifies what their HR reports were already telling them, rather than replacing that reporting.

Ready to see whether a standing retainer or a one-time assessment fits your board's current risk picture? Book a free discovery call.

```

NEW /how-does-this-connect-to-accreditation-and-compliance-risk-the-board-already-tracks

Label: Process — targets the buyer question: "How does this connect to accreditation and compliance risk the board already tracks?"

Workforce-sciences risk sits on the same board dashboard as your accreditation and compliance risk — because it drives the same outcomes surveyors, payers, and regulators already score

Boards track accreditation status, survey findings, and compliance corrective action plans as core enterprise risk. What most dashboards miss is the layer underneath those metrics: whether the people executing your standards have the regulated capacity to sustain them under pressure. Turnover in utilization management, credentialing, or case management doesn't just cost money — it produces the documentation gaps, missed timelines, and inconsistent decision-making that accreditors flag on survey. IHS built its Integral Workforce & Leadership Sciences practice specifically to close that gap, because after two decades of accreditation and compliance consulting, the pattern was unmistakable: the organizations that fail surveys or draw corrective action plans are rarely failing on paper policy. They're failing on execution, and execution failure traces back to workforce strain.

Why does a compliance-consulting firm run a workforce-sciences practice at all?

Because standards compliance is a human-execution problem before it is a documentation problem. An organization can have a technically perfect NCQA, URAC, CARF, or ACHC policy manual and still fail survey if the staff responsible for UM decisions, credentialing verification, or case management documentation are burned out, under-resourced, or operating without psychological safety to flag problems early. IHS's founder, Thomas G. Goddard, spent his career on the accreditor side — as COO and General Counsel of URAC, and on review teams for more than 200 health plans and websites — watching this exact failure mode repeat across sectors. The standards were rarely the problem. The people executing them, under conditions no standard accounts for, were.

What does the board actually see when workforce risk shows up as compliance risk?

The board sees it as a corrective action plan, a delayed survey date, a credentialing backlog, or a spike in grievances and appeals — not as a staffing or leadership problem, because those two categories are usually tracked by entirely different departments. Compliance and quality report up through one line; HR and workforce development report through another. Nobody owns the seam between them. That seam is where accreditation risk actually originates: a case manager working a caseload beyond sustainable capacity starts missing documentation windows; a credentialing team without regulated decision-making bandwidth starts approving files it should be querying; a UM staff under chronic strain starts making determinations that don't hold up on inter-rater reliability review. Each of those becomes a finding. None of them show up on a workforce dashboard until they already have.

How does IHS connect the two without turning compliance work into therapy?

IHS treats workforce capacity as an operational input to accreditation readiness, not as a wellness initiative bolted onto compliance work. The Integral Workforce & Leadership Sciences practice assesses where staff nervous-system load, role clarity, and sense of meaning and purpose are breaking down in exactly the functions accreditors audit — utilization management, case management, credentialing, and program leadership — and builds interventions aimed at restoring regulated capacity in those roles. This isn't generic engagement coaching. It's diagnostic work aimed at the specific functions where workforce strain converts directly into survey findings, corrective action plans, and turnover-driven documentation failure. The same principal-led model that governs IHS's accreditation consulting — no junior associates running the engagement — governs this work too.

Where should a board look first if it wants to see this risk before survey does?

Start with the functions that touch accreditation standards most directly — UM, case management, credentialing, and quality — and ask how long staff in those roles have held the job, what their caseloads look like against the standard's expectations, and how often near-misses get reported versus buried. Those three data points predict survey findings better than most compliance dashboards do, because they're upstream of the documentation the surveyor actually reads. IHS typically layers a workforce-capacity assessment into a standard accreditation-readiness engagement rather than running it as a separate initiative, so the board gets one integrated picture of risk instead of two disconnected reports.

Frequently asked questions

Is this a substitute for standard accreditation-readiness consulting?

No — it's a layer added to it, not a replacement for it. IHS still runs full accreditation-readiness work against the applicable standards, whether NCQA, URAC, CARF, ACHC, or another body; the workforce-sciences component addresses the human-execution risk sitting underneath those standards so the readiness work holds up after go-live, not just on the day of survey.

Which accreditation standards actually require this kind of workforce assessment?

None of the major standards mandate a formal workforce-sciences assessment by name. What they do require — consistently, across NCQA, URAC, and CARF frameworks — is staff qualification, adequate staffing ratios, and documented competency, all of which are the exact points where chronic understaffing and burnout produce the gaps surveyors cite.

Who at IHS actually does this work?

The engagement is principal-led, the same as IHS's accreditation and compliance consulting — there are no junior associates running the assessment or the intervention design.

How is this different from an employee engagement survey?

An engagement survey measures sentiment in general terms; this work is diagnostic and function-specific, aimed at the exact roles — UM, case management, credentialing — where workforce strain has a documented path to a survey finding or corrective action plan, and it produces recommendations built to close that specific path.

Does this apply to organizations that haven't had a survey finding yet?

Yes — the value is in catching capacity strain before it becomes a finding, not after. Organizations that wait until a corrective action plan forces the question have already absorbed the cost in turnover, rework, and survey risk that earlier assessment could have surfaced.

Making these pages findable by AI

Great pages only get cited if the AI engines can actually read them. Once your pages are live, confirm five things with whoever runs your site:

• The page content is in the HTML the server sends — not loaded only by JavaScript after the page opens. AI crawlers often don't run JavaScript.
• There's no login, paywall, or "are you human?" wall in front of the page.
• Your robots.txt allows the AI crawlers: GPTBot, ClaudeBot, PerplexityBot, and Google-Extended.
• Each page has a clean, readable web address (e.g. /functional-medicine-vs-conventional), not a string of numbers.
• The page is submitted to Google Search Console and Bing Webmaster Tools so it gets indexed.

None of this changes what a human visitor sees. It only makes sure the machines can read what you published.

Appendix — Paste-ready schema for your web developer

Optional, and only if you want it. Each block below is paste-ready structured data ("schema") for one of your pages. Copy the whole block — including the <script> tag — into that page's <head> so Google and AI engines can read your credentials and services. You don't need to understand it; hand it to whoever manages your website. It changes nothing a visitor sees.

SHARPEN /

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions",
      "alternateName": "IHS",
      "url": "https://www.integralhs.com/",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "honorificSuffix": "JD, PhD",
        "jobTitle": "Founder and Principal Consultant",
        "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
      },
      "employee": [
        {
          "@type": "Person",
          "name": "Susan DeMarino",
          "description": "Case management and utilization review lead; previously Vice President and Director of Accreditation at URAC and Director of Case Management at West Penn Hospital."
        },
        {
          "@type": "Person",
          "name": "Maureen Plumstead",
          "description": "NCQA expert consultant; NCQA reviewer since 1996."
        }
      ],
      "knowsAbout": [
        "URAC accreditation",
        "NCQA accreditation",
        "ACHC accreditation",
        "CARF accreditation",
        "NABP accreditation",
        "DNV GL ISO 9001",
        "HITRUST certification",
        "NCCHC accreditation",
        "AAHRPP accreditation",
        "Credentialing and CVO consulting",
        "Healthcare compliance program development",
        "Workforce and leadership sciences consulting"
      ]
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What accrediting bodies does IHS work with?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS consults across URAC, NCQA, ACHC, CARF, NABP, DNV GL, HITRUST, NCCHC, AAHRPP, and other major healthcare accrediting bodies, rather than specializing in a single one."
          }
        },
        {
          "@type": "Question",
          "name": "Who actually runs my engagement?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Thomas Goddard, IHS's founder and former COO and General Counsel of URAC, leads engagements directly, supported by principal-level subject-matter leads including Susan DeMarino and Maureen Plumstead. IHS does not staff engagements with junior associates."
          }
        },
        {
          "@type": "Question",
          "name": "Is IHS only for health plans?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. IHS works with health plans, pharmacies, credentialing organizations, behavioral health and human services providers, hospitals, correctional healthcare systems, and other organizations across the accrediting bodies relevant to their sector."
          }
        },
        {
          "@type": "Question",
          "name": "What if my organization needs more than one accreditation?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS's principal-led team covers URAC, NCQA, ACHC, CARF, NABP, and other bodies simultaneously, so organizations pursuing multiple accreditations can work with one team instead of coordinating several single-accreditor vendors."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS help with AI governance accreditation?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes. IHS tracks emerging AI governance accreditation programs, including URAC's AI Accreditation program and The Joint Commission's Responsible Use of AI in Healthcare certification developed with CHAI, and advises organizations on positioning for these newer standards."
          }
        }
      ]
    }
  ]
}
</script>

NEW /about

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Health Solutions",
  "alternateName": "IHS",
  "foundingDate": "2002",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "honorificSuffix": "JD, PhD",
    "jobTitle": "Founder and Principal",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; served as Project Manager on URAC's effort to obtain deemed status as an accreditation organization from CMS.",
    "url": "https://www.integralhs.com/about-ihs"
  },
  "employee": [
    {
      "@type": "Person",
      "name": "Susan DeMarino",
      "jobTitle": "Case Management and Utilization Review Consultant",
      "description": "Former Vice President and Director of Accreditation at URAC; formerly directed case management at West Penn Hospital."
    },
    {
      "@type": "Person",
      "name": "Maureen Plumstead",
      "jobTitle": "NCQA Expert Consultant",
      "description": "NCQA reviewer since 1996; IHS's current NCQA expert consultant."
    }
  ],
  "knowsAbout": [
    "URAC accreditation",
    "NCQA accreditation",
    "CARF accreditation",
    "ACHC accreditation",
    "DNV GL accreditation",
    "NABP accreditation",
    "HITRUST certification",
    "NCCHC accreditation",
    "CMS deemed status",
    "Healthcare compliance consulting"
  ]
}



{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is Thomas Goddard still actively involved in client engagements, or is IHS run by staff now?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS describes its delivery model as principal-led, meaning Goddard and the firm's named experts remain directly involved in client work rather than delegating engagements to junior associates."
      }
    },
    {
      "@type": "Question",
      "name": "Does IHS work across multiple accrediting bodies, or specialize in one?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS works across virtually every major healthcare accrediting body, including URAC, NCQA, CARF, ACHC, DNV, NABP, HITRUST, and NCCHC, rather than specializing narrowly in one."
      }
    },
    {
      "@type": "Question",
      "name": "Who is Susan DeMarino and what does she work on at IHS?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Susan DeMarino is a former Vice President and Director of Accreditation at URAC who also directed case management at West Penn Hospital; at IHS she works on case management and utilization review engagements."
      }
    },
    {
      "@type": "Question",
      "name": "How long has Maureen Plumstead worked with NCQA?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Maureen Plumstead has worked as an NCQA reviewer since 1996, and she serves as IHS's current NCQA expert consultant."
      }
    }
  ]
}
</script>

NEW /urac-health-care-ai-accreditation-readiness-consulting

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Do we need both Developer and User accreditation, or just one?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It depends on your organization's relationship to the AI tool. If you build or substantially customize the algorithm, Developer standards apply. If you deploy a tool built elsewhere, User standards apply. Many health plans, CVOs, and digital health platforms need both because they build some tools and license others."
      }
    },
    {
      "@type": "Question",
      "name": "How long does AI accreditation readiness typically take?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Timelines vary based on how mature an organization's existing AI governance documentation is. Organizations starting from limited formal governance structure should expect a readiness runway measured in months."
      }
    },
    {
      "@type": "Question",
      "name": "Is URAC's AI accreditation mandatory yet?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It is voluntary today for most healthcare organizations, but the emergence of a competing framework from The Joint Commission and CHAI in 2026 suggests the regulatory and purchaser landscape around AI in healthcare is moving toward expectation rather than pure option."
      }
    },
    {
      "@type": "Question",
      "name": "Can IHS help us decide whether to pursue URAC or the Joint Commission/CHAI framework?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. Comparing the two frameworks against an organization's structure, client base, and existing accreditation relationships is part of the initial readiness conversation."
      }
    },
    {
      "@type": "Question",
      "name": "Who at IHS actually does this work?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS engagements are principal-led. The person assessing standards gaps and guiding remediation is a senior consultant with direct standards-development background, not a junior associate working from a template."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "honorificSuffix": "JD, PhD",
    "jobTitle": "Founder and Principal",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS; served on URAC accreditation review teams of more than 200 HMOs, PPOs, and health websites."
  },
  "areaServed": "United States",
  "knowsAbout": [
    "URAC Artificial Intelligence in Healthcare Accreditation",
    "Healthcare AI Governance",
    "Accreditation Readiness Consulting",
    "Health Care Compliance Consulting"
  ]
}
</script>

NEW /dual-urac-ncqa-multi-body-strategy-advisory

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "Service",
  "name": "Dual URAC/NCQA & Multi-Body Accreditation Strategy Advisory",
  "provider": {
    "@type": "Organization",
    "name": "Integral Healthcare Solutions (IHS)",
    "founder": {
      "@type": "Person",
      "name": "Thomas G. Goddard",
      "jobTitle": "Founder and Principal",
      "description": "Former Chief Operating Officer and General Counsel of URAC, where he served on accreditation review teams for more than 200 HMOs, PPOs, and health websites and served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
    }
  },
  "areaServed": "United States",
  "description": "Principal-led advisory helping healthcare organizations determine whether URAC, NCQA, or both accreditations are required given their state footprint, payer contracts, and line-of-business mix, with a sequenced roadmap for dual-body accreditation."
}



{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Do we need both URAC and NCQA, or can we get by with one?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Whether you need one or both depends entirely on your payer contracts and state footprint, not on which accreditor is more prestigious. Some organizations legitimately only ever need one; others discover mid-engagement that a contract or state mandate requires the second."
      }
    },
    {
      "@type": "Question",
      "name": "Is it more expensive to pursue both accreditations at once?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Pursuing both simultaneously without shared infrastructure is more expensive, because most organizations end up duplicating policy work, documentation, and survey prep across two parallel tracks. Building the two standard sets against a shared operational core reduces that duplication substantially."
      }
    },
    {
      "@type": "Question",
      "name": "How long does it take to build out infrastructure for both bodies?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Timelines vary by how mature your current compliance infrastructure already is and whether you're pursuing the two accreditations concurrently or in sequence."
      }
    },
    {
      "@type": "Question",
      "name": "What happens if our payer contracts require an accreditation we don't currently hold?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS maps contract-required accreditation language during the initial engagement so this gets identified before it becomes a contract compliance problem. If a gap is found, the readiness plan is built around the contract deadline as a hard constraint."
      }
    },
    {
      "@type": "Question",
      "name": "Does Goddard's URAC background create any conflict when advising on NCQA strategy?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. IHS's NCQA-side work is led by consultants with direct NCQA reviewer experience, including a consultant who has served as an NCQA reviewer since 1996. Goddard's URAC background and IHS's NCQA depth are complementary."
      }
    }
  ]
}
</script>

NEW /post-merger-human-integration-for-healthcare-m-and-a-and-pe-

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Service",
      "name": "Post-Merger Human Integration for Healthcare M&A and PE",
      "provider": {
        "@type": "Organization",
        "name": "Integral Healthcare Solutions",
        "url": "https://www.integralhs.com/"
      },
      "serviceType": "Post-merger integration consulting for healthcare mergers, acquisitions, and private equity transactions",
      "areaServed": "United States",
      "description": "Consulting that combines regulatory and contractual review with grief and loss processing frameworks to address workforce disengagement, attrition risk, and compliance breakdown during healthcare M&A integration."
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is this a licensed therapy or clinical service?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. This is organizational consulting informed by grief and loss frameworks and nervous-system-informed change principles, not individual clinical treatment. Staff needing individual clinical support are referred to appropriate licensed providers; this engagement works at the organizational and leadership level."
          }
        },
        {
          "@type": "Question",
          "name": "How early in a deal should this engagement start?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Ideally during due diligence or immediately at signing, before the 100-day plan is finalized, because workforce risk factors identified early can be built into the integration timeline rather than retrofitted after attrition or compliance incidents have already occurred."
          }
        },
        {
          "@type": "Question",
          "name": "Does this replace our existing HR or change-management vendor?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. It runs alongside existing HR, benefits, and change-management functions and focuses specifically on the intersection of regulatory continuity and workforce capacity."
          }
        },
        {
          "@type": "Question",
          "name": "Who leads this work at IHS?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The engagement is led directly by IHS's principal team, not delegated to junior associates, consistent with how IHS staffs its accreditation and compliance consulting engagements."
          }
        },
        {
          "@type": "Question",
          "name": "What industries or deal types does this apply to?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Healthcare-sector mergers, acquisitions, and divestitures — health plans, hospitals, behavioral health and substance use treatment organizations, pharmacy and PBM entities, and other accredited or accreditation-seeking healthcare organizations — where clinical staff continuity and accreditation or licensure obligations are both in play."
          }
        }
      ]
    }
  ]
}
</script>

NEW /carf-behavioral-health-accreditation-for-complex-multi-site-

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is IHS a CARF-only consulting firm?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. IHS works across CARF, URAC, NCQA, ACHC, NABP, and other major healthcare accrediting bodies, which is the firm's core differentiator against single-body specialist shops."
      }
    },
    {
      "@type": "Question",
      "name": "How many CARF service lines has IHS worked with?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS maintains documented case work across a wide range of CARF service categories, including group homes, adult day services, opioid treatment programs, crisis intervention, day treatment for youth, transition services, employment planning, dementia care, and sobering centers, among others."
      }
    },
    {
      "@type": "Question",
      "name": "Why would a multi-site behavioral health organization choose a multi-body firm over a CARF specialist?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Multi-site organizations rarely face a single accreditation question in isolation. They usually manage CARF alongside payer credentialing, case management standards, or a parallel accrediting body, and a single-body specialist typically cannot advise across that whole picture."
      }
    },
    {
      "@type": "Question",
      "name": "Does working with IHS cost more than a CARF-only boutique?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Engagement scope and cost depend on the size and complexity of the organization; a single-site, single-service-line provider may find a narrower CARF-only engagement sufficient."
      }
    },
    {
      "@type": "Question",
      "name": "Who at IHS actually does the CARF preparation work?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS's engagement model keeps a principal directly involved in the client relationship and preparation work rather than delegating engagements to junior staff."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "jobTitle": "Founder and Principal",
    "alumniOf": "URAC",
    "description": "Thomas G. Goddard, JD, PhD, is the founder of Integral Healthcare Solutions and formerly served as Chief Operating Officer and General Counsel of URAC, where he served on accreditation review teams for more than 200 HMOs, PPOs, and health websites and served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
  },
  "areaServed": "United States",
  "knowsAbout": ["CARF accreditation", "URAC accreditation", "NCQA accreditation", "ACHC accreditation", "NABP accreditation", "behavioral health accreditation", "healthcare compliance consulting"]
}
</script>

NEW /340b-contract-pharmacy-independent-audit-services

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Do we need a separate audit for every contract pharmacy, or can one audit cover all of them?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Each contract pharmacy arrangement needs arrangement-level testing within the audit, even if delivered as a single consolidated report. Sampling only one or two locations and extrapolating findings across a full contract pharmacy network does not hold up under HRSA or manufacturer scrutiny."
      }
    },
    {
      "@type": "Question",
      "name": "Who is qualified to perform an independent 340B audit?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "HRSA does not certify or license 340B auditors, so independent means a party outside the entity's own compliance staff chain of accountability. IHS performs these audits led directly by senior staff rather than delegated to junior associates."
      }
    },
    {
      "@type": "Question",
      "name": "What happens if the audit finds a duplicate discount or diversion issue?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The covered entity needs a documented corrective action plan, and in duplicate discount cases, repayment to the affected payer or manufacturer. Self-identified and self-corrected findings are treated differently than those discovered externally."
      }
    },
    {
      "@type": "Question",
      "name": "How is this different from IHS's existing 340B audit guide?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The audit guide covers the 340B compliance program broadly. This page focuses specifically on the independent audit requirement for contract pharmacy arrangements, where most 340B risk concentrates."
      }
    },
    {
      "@type": "Question",
      "name": "Can IHS help if we've already had a negative finding from a manufacturer or HRSA?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. Remediation after an existing finding is a common reason covered entities engage IHS, and the same principal-led team that runs proactive audits also builds and documents corrective action plans."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Service",
  "serviceType": "340B Contract Pharmacy Independent Audit",
  "provider": {
    "@type": "Organization",
    "name": "Integral Healthcare Solutions",
    "founder": {
      "@type": "Person",
      "name": "Thomas G. Goddard",
      "jobTitle": "Founder and Principal",
      "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
    }
  },
  "description": "Independent 340B contract pharmacy audit services testing eligibility, duplicate discount prevention, and diversion prevention across all contract pharmacy arrangements, led directly by senior IHS staff.",
  "areaServed": "United States"
}
</script>

NEW /executive-coaching-for-healthcare-leaders-integrating-i-o-ps

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Service",
      "name": "Executive Coaching for Healthcare Leaders",
      "serviceType": "Executive coaching integrating organizational psychology and workforce sciences",
      "provider": {
        "@type": "Organization",
        "name": "Integral Healthcare Solutions",
        "founder": {
          "@type": "Person",
          "name": "Thomas Goddard",
          "jobTitle": "Founder and Principal",
          "description": "Former Chief Operating Officer and General Counsel of URAC"
        }
      },
      "areaServed": "United States",
      "audience": {
        "@type": "Audience",
        "audienceType": "Healthcare executives, compliance officers, and clinical leaders"
      }
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is this only for physicians?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. The coaching is built for healthcare executives, compliance officers, and operational leaders as much as clinicians — anyone whose role carries sustained regulatory or organizational pressure."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS have to be doing our accreditation work for us to use the coaching?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. The coaching is offered as a standalone service, though it draws directly on IHS's accreditation and compliance experience regardless of whether the firm is engaged on a parallel project."
          }
        },
        {
          "@type": "Question",
          "name": "How is this different from an EAP or wellness benefit?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "An employee-assistance program is typically reactive and generalized; this is proactive, leader-specific coaching grounded in the regulatory realities of the leader's own organization and role."
          }
        },
        {
          "@type": "Question",
          "name": "Who actually delivers the sessions?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Sessions are led by IHS principals with direct accreditation and compliance consulting experience, not by junior coaches or outsourced contractors."
          }
        }
      ]
    }
  ]
}
</script>

NEW /board-level-human-capital-risk-advisory-retainer

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Service",
      "name": "Board-Level Human-Capital Risk Advisory Retainer",
      "serviceType": "Human capital risk governance advisory",
      "provider": {
        "@type": "Organization",
        "name": "Integral Healthcare Solutions",
        "alternateName": "IHS"
      },
      "audience": {
        "@type": "Audience",
        "audienceType": "Boards and governance committees of health plans, health systems, CVOs, and multi-site provider organizations"
      },
      "description": "Quarterly principal-led board retainer delivering standing human-capital risk reporting, distinct from one-time culture or engagement assessments."
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "How long is the retainer term?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Retainers run on an annual agreement with quarterly delivery; terms and scope are set during a discovery call based on board size, number of entities under governance, and existing data sources."
          }
        },
        {
          "@type": "Question",
          "name": "Can the retainer scope include subsidiary or affiliate boards, not just the parent board?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes. Multi-entity governance structures are common among IHS's health plan and health system clients, and the retainer can be scoped to report at the parent level, the subsidiary level, or both."
          }
        },
        {
          "@type": "Question",
          "name": "Does the retainer produce anything usable for an accreditation survey or CMS review?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The reports are built as internal board governance documents first, but the underlying workforce risk data often overlaps with what accreditors and CMS reviewers probe, so clients frequently find it useful when preparing accreditation or regulatory documentation."
          }
        },
        {
          "@type": "Question",
          "name": "What size organization is this priced for?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Pricing depends on entity count, board structure, and data complexity and is set during a discovery call rather than published as a flat rate."
          }
        },
        {
          "@type": "Question",
          "name": "Who at IHS actually runs this?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The retainer is delivered by IHS's workforce-sciences principal, coordinated with whichever principal already leads the client's accreditation or compliance engagement."
          }
        }
      ]
    }
  ]
}
</script>

NEW /what-does-urac-s-health-care-ai-accreditation-actually-requi

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Do we need both tracks if we build our own AI tool but also let outside partners use it?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, in most cases — if you build the model, you need the Developer track regardless of who else uses it, and if you also deploy it inside your own operations, you need the User track as well. Partners who use your tool independently would need their own User-track accreditation for their deployment of it."
      }
    },
    {
      "@type": "Question",
      "name": "Can a health plan pursue User-track accreditation for a vendor's AI tool without the vendor being accredited?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A health plan can pursue User-track accreditation for its own oversight of a vendor's tool, but reviewers will still expect visibility into how that vendor built and validated the model, which is easier to document if the vendor itself holds Developer-track accreditation."
      }
    },
    {
      "@type": "Question",
      "name": "How long does AI accreditation preparation typically take?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Timelines depend on how mature your existing AI governance documentation already is; ask for a scoped estimate against your current state rather than a generic industry figure."
      }
    },
    {
      "@type": "Question",
      "name": "Does URAC's AI accreditation replace the need for HIPAA or HITRUST-type security certification?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No — URAC's Artificial Intelligence in Healthcare program addresses model governance, validation, and oversight, not data security controls, so organizations typically need both an AI accreditation and a separate security framework such as HITRUST where sensitive health data is involved."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "jobTitle": "Founder and Principal",
    "alumniOf": "URAC",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; served as Project Manager in URAC's effort to obtain deemed status as an accreditation organization from CMS."
  },
  "knowsAbout": [
    "URAC Artificial Intelligence in Healthcare Accreditation",
    "Healthcare AI governance",
    "Accreditation consulting"
  ]
}
</script>

NEW /how-do-we-prepare-governance-documentation-for-ai-risk-manag

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Do we need an AI accreditation if we're only using AI for administrative tasks?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Administrative-only AI use carries lower risk-tier expectations, but most governance frameworks still require it to appear in the inventory and be classified, even if it doesn't trigger the oversight and monitoring requirements that clinical or coverage-determination AI does."
          }
        },
        {
          "@type": "Question",
          "name": "How long does it take to build AI governance documentation from scratch?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Timelines depend on how many models are in use and how mature your existing compliance infrastructure is; organizations with an established accreditation program can often extend existing governance structures, while organizations building from zero need more runway."
          }
        },
        {
          "@type": "Question",
          "name": "Can the same documentation support both URAC AI Accreditation and Joint Commission/CHAI RUAIH certification?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Much of the underlying documentation supports both, since the two programs grade similar governance fundamentals even though their specific standards and scoring differ."
          }
        },
        {
          "@type": "Question",
          "name": "Who at our organization needs to be involved in preparing this documentation?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Typically a named accountable owner for AI governance, compliance leadership, clinical leadership if models touch clinical decisions, and technical staff who can describe how each model actually functions and fails."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS write the documentation for us or guide our team through writing it?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS works principal-led alongside client teams, drafting framework language, gap-testing it against the standard, and preparing staff for reviewer interviews, rather than handing documentation off to junior associates."
          }
        }
      ]
    },
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions",
      "url": "https://www.integralhs.com/",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "jobTitle": "Founder and Principal",
        "description": "Former COO and General Counsel of URAC"
      }
    }
  ]
}
</script>

NEW /how-does-urac-s-ai-accreditation-differ-from-the-joint-commi

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is URAC's AI accreditation required for health plans or pharmacies?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No accrediting body currently mandates AI-specific accreditation the way many states mandate NCQA accreditation for Medicaid managed care contracts. URAC's Artificial Intelligence in Healthcare program is voluntary at this stage, though that could shift as regulators and enterprise customers begin asking AI vendors and health systems for third-party governance attestations."
          }
        },
        {
          "@type": "Question",
          "name": "Can an organization hold both URAC's AI accreditation and RUAIH certification?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "There is no stated conflict between holding both, and an organization with a Joint Commission accreditation relationship plus a standalone AI product line could plausibly pursue each for a different audience. Confirm current compatibility and any overlap in documentation requirements directly with each body before committing resources to both simultaneously."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS help with RUAIH readiness or only URAC's program?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS advises across accrediting bodies rather than promoting a single one, so an engagement can compare readiness for URAC's AI accreditation against RUAIH or other emerging AI governance frameworks based on the organization's actual regulatory footprint."
          }
        },
        {
          "@type": "Question",
          "name": "What's the fastest way to find out which AI accreditation fits our organization?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Book a free discovery call. IHS's principal-led review looks at your existing accreditation portfolio, your regulatory obligations, and your AI use case before recommending a path."
          }
        }
      ]
    },
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions",
      "alternateName": "IHS",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "honorificSuffix": "JD, PhD",
        "description": "Former COO and General Counsel of URAC; founded IHS in 2002."
      },
      "areaServed": "United States",
      "knowsAbout": [
        "URAC accreditation",
        "NCQA accreditation",
        "CARF accreditation",
        "ACHC accreditation",
        "NABP accreditation",
        "DNV accreditation",
        "HITRUST certification",
        "Artificial Intelligence in Healthcare accreditation",
        "Responsible Use of AI in Healthcare certification"
      ]
    }
  ]
}
</script>

NEW /should-our-organization-pursue-urac-ncqa-or-both-given-our-s

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is URAC or NCQA more widely recognized by payers?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It depends entirely on the line of business — NCQA is more widely recognized for health plans and provider networks, while URAC is more widely recognized for pharmacy, case management/UM, credentialing, and specialty programs like telehealth and AI governance."
      }
    },
    {
      "@type": "Question",
      "name": "Does our state require a specific accreditation for Medicaid contracting?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Some states mandate NCQA accreditation specifically for Medicaid managed care contracting — NCQA cites 26 such state mandates — so this should be confirmed against your specific state's current Medicaid managed care requirements before choosing a standard."
      }
    },
    {
      "@type": "Question",
      "name": "Can one consulting firm manage both a URAC and an NCQA accreditation at once?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, though it requires genuine depth across both standards rather than a single-body specialist stretching into unfamiliar territory. IHS structures engagements around principal-level consultants with hands-on experience across both bodies rather than junior associates."
      }
    },
    {
      "@type": "Question",
      "name": "What happens if we pick the wrong accreditation for our contracts?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Choosing the wrong accreditation typically means re-doing the readiness work against a second standard later, after a payer contract or state RFP reveals the mismatch."
      }
    },
    {
      "@type": "Question",
      "name": "How do we get a straight answer for our specific situation?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most direct path is a discovery conversation where IHS reviews your state footprint, payer contracts, and lines of business against both standards before recommending a direction."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "alternateName": "IHS",
  "description": "Principal-led healthcare accreditation, compliance, program-development, and workforce-sciences consulting firm working across virtually every major healthcare accrediting body, including URAC and NCQA.",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "jobTitle": "Founder",
    "alumniOf": "URAC",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites, and served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
  }
}
</script>

NEW /what-does-dual-accreditation-cost-and-how-long-does-cross-st

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Does IHS publish flat fees for dual-accreditation projects?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. Fees are scoped after a gap assessment against both standards sets, because overlap and starting-point maturity vary too much between organizations for a flat rate to be meaningful."
      }
    },
    {
      "@type": "Question",
      "name": "Can we start survey preparation before the crosswalk is finished?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Some remediation work, such as policy updates, staff training, and documentation cleanup, can often begin as soon as early crosswalk findings are available, rather than waiting for the full mapping document to be finalized."
      }
    },
    {
      "@type": "Question",
      "name": "Which accrediting body pairs benefit most from cross-standard mapping?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Health plans pursuing NCQA and URAC together, CVOs pursuing dual URAC/NCQA credentialing status, and pharmacy organizations pursuing URAC alongside NABP accreditation tend to see the heaviest standards overlap, particularly in credentialing, utilization management, and grievance-and-appeals requirements."
      }
    },
    {
      "@type": "Question",
      "name": "Who actually does the gap mapping, a consultant or a team of associates?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The gap mapping is done by the principal assigned to the engagement, not delegated to junior staff learning the standards on the client's project."
      }
    },
    {
      "@type": "Question",
      "name": "What happens if the two accrediting bodies update their standards on different schedules?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The crosswalk is re-mapped against the updated version, which is one reason concurrent, principal-led mapping is more efficient than running two separate single-body consulting relationships."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "honorificSuffix": "JD, PhD",
    "description": "Former Chief Operating Officer and General Counsel of URAC; founder of Integral Healthcare Solutions."
  },
  "knowsAbout": [
    "URAC accreditation",
    "NCQA accreditation",
    "CARF accreditation",
    "ACHC accreditation",
    "AAAHC accreditation",
    "NABP accreditation",
    "HITRUST certification",
    "Cross-standard gap mapping",
    "Dual accreditation consulting"
  ]
}
</script>

NEW /what-specifically-does-post-merger-human-integration-add-bey

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Service",
      "name": "Post-Merger Human Integration",
      "serviceType": "Workforce and Leadership Integration Consulting",
      "provider": {
        "@type": "Organization",
        "name": "Integral Healthcare Solutions (IHS)",
        "url": "https://www.integralhs.com/"
      },
      "areaServed": "United States",
      "description": "Human integration consulting addressing leadership capacity, workforce identity, and team-level stress response gaps that standard financial and operational post-merger integration plans do not address in healthcare mergers and acquisitions."
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is this therapy or executive coaching?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "It is neither in the clinical sense — it's applied workforce and leadership sciences work aimed at organizational outcomes, not individual treatment, though it draws on nervous-system and somatic research to explain why leadership teams behave the way they do under merger stress."
          }
        },
        {
          "@type": "Question",
          "name": "Does this replace our HR or change-management function?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No — it works alongside your internal HR and change-management teams and is scoped specifically to the leadership-capacity and workforce-identity gaps that those functions typically aren't resourced or trained to diagnose."
          }
        },
        {
          "@type": "Question",
          "name": "How early should this start relative to deal close?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "As early as signing, ideally, because the leadership behaviors and communication patterns that determine whether integration succeeds get set in the first weeks, well before any formal post-close integration workstream kicks off."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS only do this for healthcare mergers?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS's principal-led team works across accreditation, compliance, program development, and workforce sciences primarily within healthcare organizations, and the post-merger human integration work is built around the specific regulatory and clinical pressures those organizations face during a merger."
          }
        }
      ]
    }
  ]
}
</script>

NEW /how-is-this-different-from-what-alvarez-and-marsal-or-charti

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Can IHS work alongside our existing advisory firm without duplicating scope?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes — IHS's scope is the accreditation, compliance, and regulatory-standards workstream specifically, which is typically outside a turnaround or strategy firm's core staffing and is defined at kickoff to avoid overlap."
          }
        },
        {
          "@type": "Question",
          "name": "Does IHS only work with PE-backed platforms, or also standalone providers and payers?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS works with a wide range of healthcare organizations — health plans, pharmacies, CVOs, behavioral health and post-acute providers, and others — with or without a private equity sponsor involved."
          }
        },
        {
          "@type": "Question",
          "name": "Which accrediting bodies does IHS cover?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS's engagements span URAC, NCQA, CARF, ACHC, DNV, NABP, and NCCHC, among others, which is broader than most single-body accreditation boutiques."
          }
        },
        {
          "@type": "Question",
          "name": "Who actually staffs an IHS engagement?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Senior, principal-level consultants staff the work directly — IHS does not delegate client engagements to junior associates."
          }
        },
        {
          "@type": "Question",
          "name": "Is IHS itself accredited or certified by anyone?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS describes itself as the only accreditation consulting firm URAC has certified under its Health Care Management Certification Program."
          }
        }
      ]
    },
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "jobTitle": "Founder and Principal",
        "honorificSuffix": "JD, PhD"
      },
      "description": "Principal-led accreditation, compliance, program-development, and workforce-sciences consulting across URAC, NCQA, CARF, ACHC, DNV, NABP, NCCHC, and other major healthcare accrediting bodies.",
      "areaServed": "United States"
    }
  ]
}
</script>

NEW /how-does-ihs-s-carf-experience-compare-to-boutique-carf-only

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is CARF the only accreditation body IHS works with?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. IHS consults across virtually every major healthcare accrediting body, including CARF, URAC, NCQA, ACHC, NABP, DNV, and NDAC, along with credentialing/CVO and compliance program engagements that often sit alongside a CARF survey."
      }
    },
    {
      "@type": "Question",
      "name": "Does IHS have staff who worked inside CARF the way Goddard worked inside URAC?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS's public-facing team background centers on senior consultants with direct experience inside accrediting and regulatory organizations, with Goddard's background specifically at URAC. Prospective clients should ask IHS directly about the specific CARF-side experience assigned to their engagement."
      }
    },
    {
      "@type": "Question",
      "name": "Can IHS handle an organization that's currently CARF-accredited but adding NCQA or URAC standards for the first time?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. This is one of the more common engagement types IHS runs, because most single-body consultants cannot follow a client across that kind of transition."
      }
    },
    {
      "@type": "Question",
      "name": "What if my organization is small and genuinely only needs CARF, with no plans to add other accreditations?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A boutique CARF specialist may be a reasonable fit in that narrow case. The comparison changes once an organization has multiple service lines, payer contracts, or a compliance program touching more than one regulator, which is common for growing providers."
      }
    },
    {
      "@type": "Question",
      "name": "How do I find out what a CARF engagement with IHS would look like for my organization?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Book a free discovery call. IHS will review the organization's current accreditation footprint, survey timeline, and any adjacent compliance or credentialing needs before scoping the engagement."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Health Solutions (IHS)",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "honorificSuffix": "JD, PhD",
    "jobTitle": "Founder",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; managed URAC's successful effort to obtain deemed status as an accreditation organization from the Centers for Medicare & Medicaid Services (CMS)."
  },
  "areaServed": "United States",
  "knowsAbout": [
    "CARF accreditation",
    "URAC accreditation",
    "NCQA accreditation",
    "ACHC accreditation",
    "NABP accreditation",
    "Healthcare compliance program development",
    "Credentialing and CVO consulting"
  ]
}
</script>

NEW /can-ihs-coordinate-carf-with-a-state-medicaid-behavioral-hea

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Does IHS work with every state's Medicaid behavioral-health credentialing program?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "IHS works across state Medicaid behavioral-health credentialing requirements as part of its broader case management and credentialing consulting practice; because requirements vary by state, the specific state program involved in an engagement is confirmed during scoping."
          }
        },
        {
          "@type": "Question",
          "name": "Do we need to already be CARF-accredited for IHS to help with Medicaid credentialing coordination?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. IHS works with organizations pursuing initial CARF accreditation, renewing existing accreditation, and organizations that are Medicaid-credentialed but not yet CARF-accredited."
          }
        },
        {
          "@type": "Question",
          "name": "How long does a combined CARF and Medicaid credentialing engagement take?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Timelines depend on the CARF survey cycle, the state's credentialing renewal calendar, and existing documentation, and are scoped during an initial discovery conversation."
          }
        },
        {
          "@type": "Question",
          "name": "Is this more expensive than hiring separate CARF and Medicaid credentialing consultants?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Coordinating both tracks in one engagement is designed to reduce duplicated policy-writing and document reconciliation; exact cost depends on scope and is discussed on a discovery call."
          }
        },
        {
          "@type": "Question",
          "name": "Who at IHS actually works on our engagement?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "A principal leads the engagement directly; IHS does not staff CARF or behavioral-health Medicaid credentialing work down to junior associates."
          }
        }
      ]
    },
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions (IHS)",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "jobTitle": "Founder",
        "description": "Former COO and General Counsel of URAC"
      },
      "employee": [
        {
          "@type": "Person",
          "name": "Susan DeMarino",
          "description": "Former Vice President and Director of Accreditation at URAC; formerly directed case management at West Penn Hospital"
        }
      ]
    }
  ]
}
</script>

NEW /does-our-contract-pharmacy-arrangement-require-an-annual-ind

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is an independent 340B audit legally required by HRSA?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. HRSA requires auditable compliance, not a specific audit vendor or cadence, but it does require the covered entity to prove the absence of diversion and duplicate discounts on demand, which is difficult to do credibly without independent verification."
      }
    },
    {
      "@type": "Question",
      "name": "What happens if we skip the audit and HRSA finds a problem?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A HRSA audit finding of diversion or duplicate discounting can require repayment to manufacturers and can jeopardize the covered entity's continued program participation, and the absence of a prior independent audit trail makes it harder to demonstrate good-faith compliance efforts during the HRSA review."
      }
    },
    {
      "@type": "Question",
      "name": "Do manufacturer restrictions change the audit requirement?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. Several manufacturers have imposed contract pharmacy restrictions that require covered entities to submit claims data or audit attestations as a condition of continued 340B pricing at contract pharmacy locations, effectively creating an audit requirement HRSA itself does not impose."
      }
    },
    {
      "@type": "Question",
      "name": "Can our own compliance staff perform this audit instead of an outside firm?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Internal staff can and should perform ongoing monitoring, but an audit performed by the same team that manages daily program operations carries an inherent independence problem that HRSA reviewers and manufacturers tend to discount; an outside audit carries more weight because it was not produced by the people being audited."
      }
    },
    {
      "@type": "Question",
      "name": "How does IHS approach a 340B contract pharmacy audit?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS conducts 340B program audits under principal-led review rather than delegating fieldwork to junior staff, and produces a documented findings report and corrective action plan built to withstand both a HRSA site visit and manufacturer scrutiny."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions (IHS)",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard, JD, PhD",
    "jobTitle": "Founder and Principal",
    "description": "Former COO and General Counsel of URAC; served on URAC accreditation review teams for more than 200 HMOs, PPOs, and health websites; served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS."
  },
  "areaServed": "United States",
  "knowsAbout": ["340B Program Compliance", "HRSA Audit Readiness", "Contract Pharmacy Compliance", "Healthcare Accreditation Consulting"]
}
</script>

NEW /what-does-ihs-s-340b-audit-methodology-cover-versus-firms-li

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is IHS a 340B-only consulting firm?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No — 340B program audits are one part of IHS's broader accreditation, compliance, program-development, and workforce-sciences consulting practice, not a standalone specialty. Clients typically engage IHS for 340B audit work alongside other regulatory or accreditation needs, delivered by the same principal team."
      }
    },
    {
      "@type": "Question",
      "name": "How is IHS different from Alinea Group or Virtue 340B?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The core audit scope overlaps substantially — split-billing accuracy, contract pharmacy oversight, eligibility documentation — but IHS delivers that work as part of an integrated compliance relationship rather than a single-purpose engagement, with senior consultants who also handle the client's accreditation and credentialing work."
      }
    },
    {
      "@type": "Question",
      "name": "Does IHS use junior staff for 340B audits?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No — IHS's stated model is principal-led delivery, meaning the consultants who scope and execute a 340B audit are the same senior team engaged on the client's other compliance and accreditation work, not junior associates working from a standardized template."
      }
    },
    {
      "@type": "Question",
      "name": "Can IHS handle 340B audits for entities pursuing accreditation at the same time?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes — because IHS runs accreditation consulting across virtually every major healthcare accrediting body, a 340B audit finding can be reconciled directly against an entity's accreditation program documentation rather than handled as a separate, disconnected process."
      }
    },
    {
      "@type": "Question",
      "name": "What HRSA compliance areas does IHS's 340B audit cover?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "IHS's 340B audit methodology covers contract pharmacy arrangement accuracy, duplicate discount prevention, GPO exclusion tracking, and eligibility documentation for both covered entity and patient-level criteria."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Integral Healthcare Solutions",
  "alternateName": "IHS",
  "founder": {
    "@type": "Person",
    "name": "Thomas G. Goddard",
    "jobTitle": "Founder and Principal",
    "honorificSuffix": "JD, PhD",
    "description": "Former Chief Operating Officer and General Counsel of URAC; served as Project Manager in URAC's successful effort to obtain deemed status as an accreditation organization from CMS; served on URAC accreditation review teams of more than 200 HMOs, PPOs, and health websites."
  },
  "areaServed": "United States",
  "knowsAbout": [
    "340B Program Audits",
    "URAC Accreditation",
    "NCQA Accreditation",
    "CARF Accreditation",
    "Healthcare Compliance Program Development",
    "Credentialing and CVO Consulting"
  ]
}
</script>

NEW /what-makes-ihs-s-executive-coaching-different-from-generic-p

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)

{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Service",
      "name": "Executive Coaching — Integral Workforce & Leadership Sciences",
      "provider": {
        "@type": "Organization",
        "name": "Integral Healthcare Solutions (IHS)",
        "founder": {
          "@type": "Person",
          "name": "Thomas G. Goddard",
          "honorificSuffix": "JD, PhD",
          "jobTitle": "Founder, Integral Healthcare Solutions; former COO and General Counsel, URAC"
        }
      },
      "serviceType": "Executive coaching for healthcare leaders under regulatory and compliance pressure",
      "audience": {
        "@type": "Audience",
        "audienceType": "Physician executives, compliance officers, health plan and health system leaders"
      },
      "description": "Principal-led executive coaching that integrates nervous-system-informed, somatic coaching methods with decades of firsthand accreditation and compliance consulting experience across NCQA, URAC, CARF, ACHC and other major healthcare accrediting bodies."
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is IHS's executive coaching only for physicians?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. While physician executives are a core audience, IHS also coaches compliance officers, health plan leaders, and other C-suite executives operating under sustained regulatory or governance pressure."
          }
        },
        {
          "@type": "Question",
          "name": "Does the coach need to understand my organization's specific accreditation status?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "It helps considerably. Because IHS coaches also work in accreditation and compliance consulting, they can often understand the regulatory pressure a client is describing without a lengthy education process, and can flag when the real fix is organizational rather than personal."
          }
        },
        {
          "@type": "Question",
          "name": "Is this coaching a substitute for therapy or medical care?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. It is executive coaching informed by somatic and nervous-system-aware methods, focused on leadership capacity. Where clinical mental health needs arise, IHS refers clients to licensed providers."
          }
        },
        {
          "@type": "Question",
          "name": "Can coaching lead into other IHS services?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes. Some clients begin with coaching and later engage IHS for accreditation readiness, compliance program development, or other consulting once a structural gap becomes clear. Others engage IHS for coaching only."
          }
        },
        {
          "@type": "Question",
          "name": "How do I get started?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Book a free discovery call to talk through what's driving the pressure you're under and whether IHS's coaching, consulting, or both are the right fit."
          }
        }
      ]
    }
  ]
}
</script>

NEW /is-coaching-billed-as-a-healthcare-specific-accreditation-ad

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is this coaching a licensed clinical or therapeutic service?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. IHS's workforce and leadership coaching is a consulting service focused on leadership capacity, organizational performance, and resilience within a healthcare regulatory context. It is not psychotherapy, clinical treatment, or a substitute for licensed mental health care."
      }
    },
    {
      "@type": "Question",
      "name": "Can we buy coaching without engaging IHS for accreditation or compliance work?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Coaching is offered as part of IHS's broader consulting relationship with healthcare organizations. Confirm with IHS whether coaching is available as a fully standalone service."
      }
    },
    {
      "@type": "Question",
      "name": "Who typically receives this coaching inside a healthcare organization?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Executives, medical directors, compliance officers, and program leaders responsible for accreditation outcomes, regulatory performance, and workforce stability."
      }
    },
    {
      "@type": "Question",
      "name": "Does the nervous-system and regulated capacity language mean this is somatic therapy?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "That language describes IHS's framework for building leadership capacity under sustained regulatory pressure. It draws on workforce-sciences and resilience concepts applied to a healthcare leadership audience, not clinical somatic therapy or a treatment claim."
      }
    },
    {
      "@type": "Question",
      "name": "How does this differ from a general executive coaching firm?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A general executive coaching firm is not built around healthcare's accreditation and regulatory cycles. IHS's coaching is delivered by the same principal-led team that runs accreditation and compliance engagements across most major healthcare accrediting bodies."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Service",
  "name": "Workforce and Leadership Coaching for Healthcare Organizations",
  "provider": {
    "@type": "Organization",
    "name": "Integral Healthcare Solutions",
    "founder": {
      "@type": "Person",
      "name": "Thomas G. Goddard"
    }
  },
  "serviceType": "Healthcare workforce and leadership coaching, accreditation-adjacent consulting",
  "areaServed": "United States",
  "audience": {
    "@type": "Audience",
    "audienceType": "Healthcare executives, medical directors, compliance officers, program leaders"
  }
}
</script>

NEW /what-does-a-quarterly-board-retainer-on-human-capital-risk-a

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "How long is the typical retainer engagement?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Retainers are structured as ongoing quarterly cycles rather than fixed-term projects, renewed based on the board's continued need for standing workforce-risk visibility rather than a preset end date. Organizations moving through an active accreditation cycle or leadership transition often keep the retainer running through that period and reassess afterward."
      }
    },
    {
      "@type": "Question",
      "name": "Who presents the quarterly briefing to the board?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The principal consultant assigned to the engagement delivers the briefing directly — there is no handoff to a junior associate for board-facing work. This follows the same principal-led model IHS applies across its accreditation and compliance consulting."
      }
    },
    {
      "@type": "Question",
      "name": "Can the retainer run alongside an active accreditation engagement?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes — this is one of the more common configurations, since workforce risk and accreditation standing are frequently linked through staffing, credentialing, and leadership-stability requirements. The two workstreams are coordinated so the board sees a single coherent risk picture."
      }
    },
    {
      "@type": "Question",
      "name": "What size organization is this designed for?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The retainer model works for any organization with a functioning board or board committee and enough workforce scale that risk indicators are meaningful to track quarter over quarter. Very small organizations without a formal governance structure are usually better served by a one-time assessment."
      }
    },
    {
      "@type": "Question",
      "name": "Does the retainer replace our existing HR reporting?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No — it sits above and alongside existing HR and operational reporting, translating it into board-level risk terms rather than duplicating departmental metrics."
      }
    }
  ]
}



{
  "@context": "https://schema.org",
  "@type": "Service",
  "serviceType": "Quarterly Human-Capital Risk Retainer",
  "provider": {
    "@type": "Organization",
    "name": "Integral Healthcare Solutions",
    "founder": {
      "@type": "Person",
      "name": "Thomas G. Goddard"
    }
  },
  "description": "Standing quarterly board-level review of human-capital and workforce risk indicators, delivered principal-led and coordinated with active accreditation and compliance engagements where applicable."
}
</script>

NEW /how-does-this-connect-to-accreditation-and-compliance-risk-t

<script type="application/ld+json">
Schema to paste in the page <head> (hygiene — aids extraction, not a ranking lever)


{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "Is this a substitute for standard accreditation-readiness consulting?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No — it's a layer added to it, not a replacement for it. IHS still runs full accreditation-readiness work against the applicable standards, whether NCQA, URAC, CARF, ACHC, or another body; the workforce-sciences component addresses the human-execution risk sitting underneath those standards so the readiness work holds up after go-live, not just on the day of survey."
          }
        },
        {
          "@type": "Question",
          "name": "Which accreditation standards actually require this kind of workforce assessment?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "None of the major standards mandate a formal workforce-sciences assessment by name. What they do require — consistently, across NCQA, URAC, and CARF frameworks — is staff qualification, adequate staffing ratios, and documented competency, all of which are the exact points where chronic understaffing and burnout produce the gaps surveyors cite."
          }
        },
        {
          "@type": "Question",
          "name": "Who at IHS actually does this work?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The engagement is principal-led, the same as IHS's accreditation and compliance consulting — there are no junior associates running the assessment or the intervention design."
          }
        },
        {
          "@type": "Question",
          "name": "How is this different from an employee engagement survey?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "An engagement survey measures sentiment in general terms; this work is diagnostic and function-specific, aimed at the exact roles — UM, case management, credentialing — where workforce strain has a documented path to a survey finding or corrective action plan, and it produces recommendations built to close that specific path."
          }
        },
        {
          "@type": "Question",
          "name": "Does this apply to organizations that haven't had a survey finding yet?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes — the value is in catching capacity strain before it becomes a finding, not after. Organizations that wait until a corrective action plan forces the question have already absorbed the cost in turnover, rework, and survey risk that earlier assessment could have surfaced."
          }
        }
      ]
    },
    {
      "@type": "Organization",
      "name": "Integral Healthcare Solutions",
      "alternateName": "IHS",
      "founder": {
        "@type": "Person",
        "name": "Thomas G. Goddard",
        "jobTitle": "Founder",
        "description": "Former COO and General Counsel of URAC"
      },
      "url": "https://www.integralhs.com/"
    }
  ]
}
</script>